<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:19Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5025723" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5025723</identifier><datestamp>2016-10-03</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Traffic</journal-id>
      <journal-id journal-id-type="iso-abbrev">Traffic</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1600-0854</journal-id>
      <journal-id journal-id-type="publisher-id">TRA</journal-id>
      <journal-title-group>
        <journal-title>Traffic (Copenhagen, Denmark)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1398-9219</issn>
      <issn pub-type="epub">1600-0854</issn>
      <publisher>
        <publisher-name>John Wiley &amp; Sons A/S</publisher-name>
        <publisher-loc>Former Munksgaard</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5025723</article-id>
      <article-id pub-id-type="pmcid">PMC5025723</article-id>
      <article-id pub-id-type="pmc-uid">5025723</article-id>
      <article-id pub-id-type="pmid">27126989</article-id>
      <article-id pub-id-type="doi">10.1111/tra.12409</article-id>
      <article-id pub-id-type="publisher-id">TRA12409</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Genetic Screen Identifies a Critical Role for the <styled-content style="fixed-case">WDR81âWDR91</styled-content> Complex in the Trafficking and Degradation of Tetherin</article-title>
        <alt-title alt-title-type="right-running-head">The <styled-content style="fixed-case">WDR81âWDR91</styled-content> Complex Regulates Protein Trafficking</alt-title>
        <alt-title alt-title-type="left-running-head">Rapiteanu et al.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="tra12409-cr-0001" contrib-type="author">
          <name>
            <surname>Rapiteanu</surname>
            <given-names>Radu</given-names>
          </name>
          <xref ref-type="aff" rid="tra12409-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="tra12409-cr-0002" contrib-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>Luther J.</given-names>
          </name>
          <xref ref-type="aff" rid="tra12409-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="tra12409-cr-0003" contrib-type="author">
          <name>
            <surname>Williamson</surname>
            <given-names>James C.</given-names>
          </name>
          <xref ref-type="aff" rid="tra12409-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="tra12409-cr-0004" contrib-type="author">
          <name>
            <surname>Timms</surname>
            <given-names>Richard T.</given-names>
          </name>
          <xref ref-type="aff" rid="tra12409-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="tra12409-cr-0005" contrib-type="author">
          <name>
            <surname>Paul Luzio</surname>
            <given-names>J.</given-names>
          </name>
          <xref ref-type="aff" rid="tra12409-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="tra12409-cr-0006" contrib-type="author" corresp="yes">
          <name>
            <surname>Lehner</surname>
            <given-names>Paul J.</given-names>
          </name>
          <xref ref-type="aff" rid="tra12409-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="tra12409-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Cambridge Institute for Medical Research</named-content>
        <institution>University of Cambridge School of Clinical Medicine, Wellcome Trust/MRC Building Biomedical Campus</institution>
        <named-content content-type="city">Cambridge</named-content>
        <named-content content-type="post-code">CB2 0XY</named-content>
        <country country="GB">UK</country>
      </aff>
      <aff id="tra12409-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Departments of Medicine and Clinical Biochemistry</named-content>
        <institution>University of Cambridge School of Clinical Medicine, Wellcome Trust/MRC Building Biomedical Campus</institution>
        <named-content content-type="city">Cambridge</named-content>
        <named-content content-type="post-code">CB2 0XY</named-content>
        <country country="GB">UK</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>Corresponding author: Paul J. Lehner, <email>pjl30@cam.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <volume>17</volume>
      <issue>8</issue>
      <issue-id pub-id-type="doi">10.1111/tra.2016.17.issue-8</issue-id>
      <issue-title content-type="special-issue-title">Myosins in review</issue-title>
      <fpage>940</fpage>
      <lpage>958</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>26</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. <italic>Traffic</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
        <license license-type="creativeCommonsBy-nc-nd">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:TRA-17-940.pdf"/>
      <abstract id="tra12409-abs-0002">
        <p id="tra12409-para-0007">Tetherin (<styled-content style="fixed-case">BST2</styled-content>/<styled-content style="fixed-case">CD317</styled-content>) is a viral restriction factor that anchors enveloped viruses to host cells and limits viral spread. The <styled-content style="fixed-case">HIV</styled-content>â1 Vpu accessory protein counteracts tetherin by decreasing its cell surface expression and targeting it for ubiquitinâdependent endolysosomal degradation. Although the Vpuâmediated downregulation of tetherin has been extensively studied, the molecular details are not completely elucidated. We therefore used a forward genetic screen in human haploid <styled-content style="fixed-case">KBM7</styled-content> cells to identify novel genes required for tetherin trafficking. Our screen identified <styled-content style="fixed-case">WDR81</styled-content> as a novel gene required for tetherin trafficking and degradation in both the presence and absence of Vpu. <styled-content style="fixed-case">WDR81</styled-content> is a <styled-content style="fixed-case">BEACH</styled-content>âdomain containing protein that is also required for the degradation of <styled-content style="fixed-case">EGF</styled-content>âstimulated epidermal growth factor receptor (<styled-content style="fixed-case">EGFR</styled-content>) and functions in a complex with the <styled-content style="fixed-case">WDR91</styled-content> protein. In the absence of <styled-content style="fixed-case">WDR81</styled-content> the endolysosomal compartment appears swollen, with enlarged early and late endosomes and reduced delivery of endocytosed dextran to cathepsinâactive lysosomes. Our data suggest a role for the <styled-content style="fixed-case">WDR81âWDR91</styled-content> complex in the fusion of endolysosomal compartments and the absence of <styled-content style="fixed-case">WDR81</styled-content> leads to impaired receptor trafficking and degradation.</p>
        <p>
<inline-graphic xlink:href="TRA-17-940-g007.jpg" xlink:title="image"/>
</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="tra12409-kwd-0001">
          <styled-content style="fixed-case">CAMRQ2</styled-content>
        </kwd>
        <kwd id="tra12409-kwd-0002">early endosomes</kwd>
        <kwd id="tra12409-kwd-0003">EGFR</kwd>
        <kwd id="tra12409-kwd-0004">endocytosis</kwd>
        <kwd id="tra12409-kwd-0005"><styled-content style="fixed-case">HIV</styled-content>âVpu</kwd>
        <kwd id="tra12409-kwd-0006">human haploid cells</kwd>
        <kwd id="tra12409-kwd-0007">
          <styled-content style="fixed-case">KBM7</styled-content>
        </kwd>
        <kwd id="tra12409-kwd-0008">lysosomes</kwd>
        <kwd id="tra12409-kwd-0009">tetherin</kwd>
        <kwd id="tra12409-kwd-0010">
          <styled-content style="fixed-case">WDR81</styled-content>
        </kwd>
        <kwd id="tra12409-kwd-0011">
          <styled-content style="fixed-case">WDR91</styled-content>
        </kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Wellcome Trust</funding-source>
          <award-id>084957/Z/08/Z</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>MRC Research Grant</funding-source>
          <award-id>MR/M010007/1</award-id>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="19"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>tra12409</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>August 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:16.09.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p id="tra12409-para-0008">As obligate intracellular parasites, viruses have evolved multiple strategies to manipulate host cellular pathways, to enable their replication and evade immune detection. Conversely, mammalian cells have developed restriction factors that limit or prevent different stages of viral replication. The study of how viruses target host factors has provided key insights into our understanding of viral pathogenesis as well as fundamental aspects of host cell biology.</p>
    <p id="tra12409-para-0009">A good example of this is the HIV1âVpu mediated downregulation of the viral restriction factor, tetherin (BST2/CD317). Tetherin inhibits the release of a wide spectrum of enveloped viruses, including human immunodeficiency virus (HIV) and Ebola, from infected cells <xref rid="tra12409-bib-0001" ref-type="ref">1</xref>, <xref rid="tra12409-bib-0002" ref-type="ref">2</xref>, <xref rid="tra12409-bib-0003" ref-type="ref">3</xref>, <xref rid="tra12409-bib-0004" ref-type="ref">4</xref>, <xref rid="tra12409-bib-0005" ref-type="ref">5</xref>, <xref rid="tra12409-bib-0006" ref-type="ref">6</xref>, <xref rid="tra12409-bib-0007" ref-type="ref">7</xref>, <xref rid="tra12409-bib-0008" ref-type="ref">8</xref>, <xref rid="tra12409-bib-0009" ref-type="ref">9</xref>, <xref rid="tra12409-bib-0010" ref-type="ref">10</xref>, <xref rid="tra12409-bib-0011" ref-type="ref">11</xref>, <xref rid="tra12409-bib-0012" ref-type="ref">12</xref>, <xref rid="tra12409-bib-0013" ref-type="ref">13</xref>. Tetherin achieves this by targeting the lipid bilayer of the viral envelope, a molecular component that cannot be mutated or eliminated. Tetherin is an interferon inducible, transmembrane protein with an unusual topology, that is key to its antiviral function. It encodes an extended extraâcellular alpha helix with both extremities embedded in cellular membranes using different anchors: an Nâterminal transmembrane domain and a Câterminal glycosylphosphatidylâinositol (GPI) anchor <xref rid="tra12409-bib-0014" ref-type="ref">14</xref>, <xref rid="tra12409-bib-0015" ref-type="ref">15</xref>, <xref rid="tra12409-bib-0016" ref-type="ref">16</xref>, <xref rid="tra12409-bib-0017" ref-type="ref">17</xref>. This allows tetherin to form disulphide linked homodimers and anchor virions to cellular membranes through its terminal domains <xref rid="tra12409-bib-0017" ref-type="ref">17</xref>, <xref rid="tra12409-bib-0018" ref-type="ref">18</xref>, <xref rid="tra12409-bib-0019" ref-type="ref">19</xref>. Beyond limiting the spread of viruses, the tetherinâmediated accumulation of virions at the plasma membrane (PM) enhances antibody opsonisation <xref rid="tra12409-bib-0020" ref-type="ref">20</xref>, <xref rid="tra12409-bib-0021" ref-type="ref">21</xref>, <xref rid="tra12409-bib-0022" ref-type="ref">22</xref>, <xref rid="tra12409-bib-0023" ref-type="ref">23</xref>, leads to virion endocytosis <xref rid="tra12409-bib-0001" ref-type="ref">1</xref>, <xref rid="tra12409-bib-0024" ref-type="ref">24</xref> and can induce proinflammatory NFâkB signalling <xref rid="tra12409-bib-0025" ref-type="ref">25</xref>, <xref rid="tra12409-bib-0026" ref-type="ref">26</xref>, <xref rid="tra12409-bib-0027" ref-type="ref">27</xref>. Tetherin localizes not only to PM lipid rafts but also to endocytic compartments and the transâGolgi network (TGN) <xref rid="tra12409-bib-0014" ref-type="ref">14</xref>. Its Nâterminal cytoplasmic tail contains the YDYCRV endocytic motif which binds the AP1 and AP2 clathrin adaptors and facilitates the endocytic recycling of tetherin via the TGN <xref rid="tra12409-bib-0028" ref-type="ref">28</xref>.</p>
    <p id="tra12409-para-0010">The HIVâ1 encoded accessory protein Vpu counteracts the inhibitory effects of tetherin, the HIVâ1 receptor CD4 and the amino acid transporter SNAT1. Vpu uses its DSGNES phosphodegron to recruit the same SCF<sup>Î²TrCP2</sup> E3 ubiquitin ligase complex to facilitate the ubiquitination of tetherin <xref rid="tra12409-bib-0029" ref-type="ref">29</xref>, <xref rid="tra12409-bib-0030" ref-type="ref">30</xref>, <xref rid="tra12409-bib-0031" ref-type="ref">31</xref>, <xref rid="tra12409-bib-0032" ref-type="ref">32</xref>, CD4 <xref rid="tra12409-bib-0033" ref-type="ref">33</xref> and SNAT1 <xref rid="tra12409-bib-0034" ref-type="ref">34</xref>, but targets the different proteins in distinct compartments and enhances their degradation via different mechanisms. Vpu traps newly synthesized CD4 in the ER and promotes its degradation through ERâassociated protein degradation (ERAD) <xref rid="tra12409-bib-0033" ref-type="ref">33</xref>, <xref rid="tra12409-bib-0035" ref-type="ref">35</xref>. In contrast to CD4 degradation, tetherin antagonism is abolished by artificial retention of Vpu in the ER <xref rid="tra12409-bib-0036" ref-type="ref">36</xref> as Vpu targets tetherin in a postâER compartment <xref rid="tra12409-bib-0036" ref-type="ref">36</xref>. The tetherinâVpu interaction occurs via their respective transmembrane domains and leads to a reduction of tetherin levels at the cell surface <xref rid="tra12409-bib-0019" ref-type="ref">19</xref>, <xref rid="tra12409-bib-0037" ref-type="ref">37</xref>, <xref rid="tra12409-bib-0038" ref-type="ref">38</xref>. Nevertheless, Vpu has little effect on the rate of PM endocytosis of tetherin <xref rid="tra12409-bib-0039" ref-type="ref">39</xref>, <xref rid="tra12409-bib-0040" ref-type="ref">40</xref>, <xref rid="tra12409-bib-0041" ref-type="ref">41</xref> but rather interferes with the delivery of newly synthesized tetherin to the PM and with tetherin recycling via the TGN <xref rid="tra12409-bib-0039" ref-type="ref">39</xref>, <xref rid="tra12409-bib-0041" ref-type="ref">41</xref>. Consistent with the notion that Vpu prevents access of tetherin to the PM is the observation that both tetherin and Vpu colocalize mainly to TGN compartments in HIVâinfected cells <xref rid="tra12409-bib-0042" ref-type="ref">42</xref>, <xref rid="tra12409-bib-0043" ref-type="ref">43</xref>. Tetherin downregulation from the PM relies on clathrinâmediated endocytosis <xref rid="tra12409-bib-0040" ref-type="ref">40</xref>, <xref rid="tra12409-bib-0043" ref-type="ref">43</xref>, Rab7 GTPase <xref rid="tra12409-bib-0044" ref-type="ref">44</xref> and the endosomal sorting complex required for transport (ESCRT) proteins HRS <xref rid="tra12409-bib-0045" ref-type="ref">45</xref>, TSG101 <xref rid="tra12409-bib-0045" ref-type="ref">45</xref> and UBAP1 <xref rid="tra12409-bib-0046" ref-type="ref">46</xref>.</p>
    <p id="tra12409-para-0011">Despite significant advances in our mechanistic understanding of Vpuâmediated antagonism of tetherin, the molecular details are not fully elucidated <xref rid="tra12409-bib-0012" ref-type="ref">12</xref>, <xref rid="tra12409-bib-0047" ref-type="ref">47</xref>. For example, there is controversy surrounding Vpu's E<sub>59</sub>XXXLV<sub>64</sub> motif. EXXXLV mutants can bind tetherin, the SCF<sup>Î²TrCP2</sup> complex and HRS and yet have limited capability in decreasing cell surface expression or degradation of tetherin <xref rid="tra12409-bib-0048" ref-type="ref">48</xref>. Furthermore, both Vpu EXXXLV mutants and tetherin are present at the PM and both are incorporated in nascent virions <xref rid="tra12409-bib-0048" ref-type="ref">48</xref>. This suggested that Vpu's E<sub>59</sub>XXXLV<sub>64</sub> motif might facilitate interaction with other, unknown components of the cellular machinery. Moreover, the requirement for SCF<sup>Î²TrCP2</sup> in the Vpuâmediated downregulation of PM tetherin has been much debated <xref rid="tra12409-bib-0030" ref-type="ref">30</xref>, <xref rid="tra12409-bib-0031" ref-type="ref">31</xref>, <xref rid="tra12409-bib-0037" ref-type="ref">37</xref>, <xref rid="tra12409-bib-0041" ref-type="ref">41</xref>, <xref rid="tra12409-bib-0049" ref-type="ref">49</xref>. A recent study addressed these issues and showed that SCF<sup>Î²TrCP2</sup> is essential for the Vpuâmediated degradation of tetherin but dispensable for tetherin downregulation from the PM in HIVâ1 infected cells <xref rid="tra12409-bib-0050" ref-type="ref">50</xref>. Furthermore, phosphorylation of Vpu's DSGNES motif serves not only for the recruitment of SCF<sup>Î²TrCP2</sup>, but is also required along with the intact E<sub>59</sub>XXXLV<sub>64</sub> motif for binding to either clathrin adaptors APâ1 or APâ2 <xref rid="tra12409-bib-0050" ref-type="ref">50</xref>, <xref rid="tra12409-bib-0051" ref-type="ref">51</xref>.</p>
    <p id="tra12409-para-0012">To further understand the molecular machinery required for Vpuâmediated tetherin downregulation and degradation, we used a novel approach in the form of a forward genetic screen in Vpuâexpressing KBM7 cells. This methodology has proven successful in enabling the identification and characterization of novel genes required for viral entry <xref rid="tra12409-bib-0052" ref-type="ref">52</xref> as well as intracellular viral evasion pathways <xref rid="tra12409-bib-0053" ref-type="ref">53</xref>, <xref rid="tra12409-bib-0054" ref-type="ref">54</xref>, <xref rid="tra12409-bib-0055" ref-type="ref">55</xref>. Our screen identified WDR81, a poorly characterized BEACH domain containing protein we find to be required for tetherin trafficking and degradation in both the presence and absence of Vpu. Upon WDR81 depletion, tetherin accumulates in enlarged endocytic vesicles/compartments. Furthermore, our data show that the loss of WDR81 delays the delivery of endocytosed fluid phase cargo to lysosomes and inhibits degradation of the EGFR. We find that WDR81 forms a complex with WDR91 and this interaction is critical for function. Therefore, by studying tetherin trafficking in mammalian cells, we have identified a WDR81âWDR91 complex responsible for maintaining the morphology and function of the endolysosomal pathway.</p>
    <sec id="tra12409-sec-0002">
      <title>Results</title>
      <sec id="tra12409-sec-0003">
        <title>A haploid genetic screen identifies a requirement for WDR81 in the Vpuâmediated downregulation of tetherin</title>
        <p id="tra12409-para-0013">To identify novel host factors required for the HIV1âVpuâmediated downregulation and degradation of tetherin and CD4, we performed a forward genetic screen in human nearâhaploid KBM7 cells. We predicted that disruption of a gene essential for Vpu function would interfere with tetherin or CD4 downregulation and increase their cell surface expression, resulting in tetherin<sup>high</sup> and/or CD4<sup>high</sup> cells (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>A). We created a cell line expressing HIVâ1 NL4.3 Vpu internal ribosome entry site (IRES) CFP (VpuâCFP) (Figure S1A, Supporting Information) and selected clones with low cellâsurface expression of endogenous tetherin and CD4. A total of three VpuâCFP clones were pooled and transduced with a geneâtrap retrovirus, at an MOI of 1 to prevent multiple retroviral geneâtrap mutations per cell. Seven days postâmutagenesis, rare VpuâKBM7 cells that were either tetherin<sup>high</sup>CFP<sup>high</sup> or CD4<sup>high</sup>CFP<sup>high</sup> (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>A) were selected by fluorescenceâactivated cell sorting (FACS). The sorting gates were designed to avoid rare cells which have lost Vpu expression and thus became both tetherin<sup>high</sup> and CD4<sup>high</sup> (Figure S1B). Seven days after the first selection, the CD4<sup>high</sup> population underwent a second FACS enrichment, which allowed visualization of a CD4<sup>high</sup> tetherin<sup>low</sup> cell population (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>A), from which genomic DNA was extracted. The retroviral geneâtrap integration sites from this enriched CD4<sup>high</sup> population were sequenced and mapped back to the genome resulting in the identification of three genes that were significantly enriched for inactivating insertions compared to an unselected control population <xref rid="tra12409-bib-0053" ref-type="ref">53</xref>: <italic>Î²TrCP2 (FBXW11), CUL1</italic> and <italic>UBE2M</italic> (Figure S1C). The discovery of these genes validated our genetic approach as they are all members of the SCF<sup>Î²TrCP2</sup> E3 ubiquitin ligase complex, known to be recruited by Vpu to facilitate the ubiquitination and subsequent degradation of CD4 <xref rid="tra12409-bib-0029" ref-type="ref">29</xref>, <xref rid="tra12409-bib-0030" ref-type="ref">30</xref>, <xref rid="tra12409-bib-0031" ref-type="ref">31</xref>, <xref rid="tra12409-bib-0032" ref-type="ref">32</xref>, <xref rid="tra12409-bib-0033" ref-type="ref">33</xref>. Although depletion of Î²TrCP2 in Vpuâexpressing KBM7 cells (Figure S1D) restores PM levels of CD4, cell surface expression of tetherin is not rescued, explaining why component genes of the SCF<sup>Î²TrCP2</sup> complex were not identified as hits in the tetherin<sup>high</sup> screen. These findings are in agreement with a recent study that found Î²TrCP2 to be dispensable for the Vpuâmediated downregulation of tetherin from the PM <xref rid="tra12409-bib-0050" ref-type="ref">50</xref>. We observed the same effect, with a full rescue of PM CD4 levels but no restoration of cell surface tetherin, when depleting Î²TrCP2 in Vpuâexpressing CEMT4 cells, a human leukemic CD4+ Tâcell line used in HIV studies (Figure S1E). CEMT4 cells appear more susceptible to CRISPRâCas9âmediated editing, showing better knockâout (KO) efficiency than KBM7 cells (compare Figure S1D with E and data not shown) and were thus used for the validation of further hits.</p>
        <fig fig-type="Figure" xml:lang="en" id="tra12409-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>
<bold>A haploid genetic screen identifies a requirement for WDR81 in the Vpuâmediated downregulation of tetherin.</bold> A) Nearâhaploid VpuâKBM7 cell clones were mutagenised with geneâtrap retroviruses and rare CD4<sup>high</sup> cells selected by two sequential rounds of FACS. Rare tetherin<sup>high</sup> cells were selected by one round of FACS. Approximate sorting gates are indicated. Schematic drawings of cells at various stages of the genetic screen are shown above or below respective scatterplots. Black spikes represent CD4, red spikes represent tetherin. B) Bubble plot illustrating the hits from the tetherin<sup>high</sup> screen. Bubble size is proportional to the number of independent inactivating geneâtrap integrations identified (shown in brackets). C) Sequencing of retroviral insertion sites in the selected tetherin<sup>high</sup> population revealed 44 independent inactivating insertions (red triangles) in the WDR81 gene on chromosome 17. Grey rectangles represent exons.</p>
          </caption>
          <graphic id="nlm-graphic-3" xlink:href="TRA-17-940-g004">
            <alt-text>TRA-12409-FIG-0001-c</alt-text>
          </graphic>
        </fig>
        <p id="tra12409-para-0014">A second FACS enrichment on the tetherin<sup>high</sup> population was unsuccessful as following selection the majority of the sorted cells died. Genomic DNA was therefore extracted from cells recovered from the first tetherin<sup>high</sup> sort (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>A). Mapping of these geneâtrap integration sites identified four genes: <italic>VPS33a</italic>, <italic>VPS39</italic>, <italic>TSC2</italic> and <italic>WDR81</italic> (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>B). VPS33a and VPS39 are known components of the homotypic fusion and vacuole protein sorting complex (HOPS) <xref rid="tra12409-bib-0056" ref-type="ref">56</xref>, <xref rid="tra12409-bib-0057" ref-type="ref">57</xref>, <xref rid="tra12409-bib-0058" ref-type="ref">58</xref>. The HOPS complex is essential for endosomal maturation <xref rid="tra12409-bib-0059" ref-type="ref">59</xref>, delivery of cargo to lysosomes <xref rid="tra12409-bib-0060" ref-type="ref">60</xref>, <xref rid="tra12409-bib-0061" ref-type="ref">61</xref> and fusion of autophagosomes with late endosomes/lysosomes <xref rid="tra12409-bib-0062" ref-type="ref">62</xref>. TSC2 is a negative regulator of the mTORC1 complex [reviewed in <xref rid="tra12409-bib-0063" ref-type="ref">63</xref>] and has also been described as a Rab5 GTPase activating protein (GAP) <xref rid="tra12409-bib-0064" ref-type="ref">64</xref>, <xref rid="tra12409-bib-0065" ref-type="ref">65</xref>. We chose to focus on the top hit, <italic>WDR81,</italic> a large and poorly characterized gene which had 44 independent trapping integrations in transcript 1 (ENST00000409644) (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>C).</p>
        <p id="tra12409-para-0015">To verify the requirement for WDR81 in the Vpuâmediated downregulation of tetherin, we used the CRISPRâCas9 system to KO WDR81 in CEMT4 cells. We confirmed depletion of WDR81 in the sgRNAâtargeted CEMT4 cell population, as the predicted 210âkDa WDR81 band detected in control CEMT4 cells was markedly reduced in the WDR81KO mixed cell population (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>A). Immunoblot analysis showed that the Vpuâmediated decrease in tetherin levels seen in VpuâCEMT4 cells (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>A, lane 2 and three replicates quantified in B) was rescued following depletion of WDR81 (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>A, lane 3 and three replicates quantified in B). Furthermore, even in the absence of Vpu, depletion of WDR81 caused a significant increase in tetherin levels (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>A, lane 4, and three replicates quantified in B). Interestingly, the marked increase in the intracellular tetherin pool resulted in only a modest rescue (1.6âfold) of cell surface tetherin in WDR81âdepleted, VpuâCEMT4s (Figure S2A and three replicates quantified in B), suggesting that accumulation of cellular tetherin occurs predominantly in an intracellular compartment.</p>
        <fig fig-type="Figure" xml:lang="en" id="tra12409-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>
<bold>Depletion of WDR81 results in accumulation of tetherin in vesicular compartments in both the presence and absence of Vpu.</bold> A) WDR81 and tetherin expression was assessed by immunoblotting control and WDR81 depleted CEMT4 cells Â± Vpu. B) Tetherin levels from three independent experiments using cells in âAâ were quantified with Image J and normalized by loading. Histograms represent mean normalized tetherin signal Â±SEM. *p â¤ 0.05, **p â¤ 0.01, ***p â¤ 0.001. C) WDR81 expression was assessed by immunoblot in HeLa cell clones Â± Vpu stably expressing Cas9 and two independent WDR81 specific sgRNAs. D) Confocal microscopy images of endogenous tetherin using cells in âCâ. Cell edges in Vpu expressing cells are outlined in red. E) HeLa cells were depleted of WDR81 by transient expression of Cas9 and WDR81 sgRNA#1 and single cell cloned. Exogenous expression of 2ÃHAâWDR81 in these WDR81KO clones was analysed by immunoblot. F) Immunostaining of endogenous tetherin in control, WDR81KO clones and WDR81KO clones genetically complemented with exogenous WDR81 or 2ÃHAâWDR81. G) Immunostaining of tetherin and 2HAâWDR81 in genetically complemented WDR81KO cells (prior to blasticidin selection). All scale bars represent 10 Âµm.</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="TRA-17-940-g001">
            <alt-text>TRA-12409-FIG-0002-c</alt-text>
          </graphic>
        </fig>
        <p id="tra12409-para-0016">To identify where tetherin accumulates in the absence of WDR81, we generated HeLa cell clones deficient in WDR81 (HeLaâWDR81KO) Â± Vpu. Two independent sgRNAs targeting WDR81 exon 4 and 5 generated WDR81 deficient clones as confirmed using immunoblot analysis (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>C). Vpu was stably expressed in WDR81 knockout clones and control HeLa cells and, as expected, both flow cytometry and confocal immunofluorescence microscopy confirmed that both the cell surface and the intracellular pool of tetherin was reduced in Vpuâexpressing HeLa cells (Figure S2C and D). In the two WDR81âknockout clones, tetherin accumulated in swollen, perinuclear, vesicular compartments in both the presence and absence of Vpu (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>D). To confirm this observation and exclude possible artefacts associated with stable Cas9 and sgRNA expression, we carried out a rescue experiment. First, we created a further WDR81KO HeLa cell line by transient expression of Cas9 and WDR81âsgRNA #1 (targeting WDR81 exon 5). Single cell clones were selected and loss of WDR81 again confirmed (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>E). The intracellular accumulation of tetherin seen in the WDR81KO clone was rescued by stable expression of WDR81 [untagged or Nâterminus 2ÃHA tagged (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>E)], confirming that loss of WDR81 was responsible for the observed phenotype (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>F). Furthermore, the accumulation of tetherin in swollen vesicular compartments was only seen in those cells not complemented by 2ÃHAâWDR81 (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>G). Thus, we validated WDR81 as required for tetherin trafficking and degradation.</p>
      </sec>
      <sec id="tra12409-sec-0004">
        <title>WDR81 is a BEACH domain containing protein that associates with endolysosomal membranes</title>
        <p id="tra12409-para-0017">WDR81 is a 1941 amino acid, Beach (after âBeige and ChediakâHigashiâ) domain containing protein (BDCP) with five Câterminal WD40 domains (Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>A). Of the nine known human BDCPs, LYST is the best studied and is mutated in ChediakâHigashi syndrome (CHS) <xref rid="tra12409-bib-0066" ref-type="ref">66</xref>, <xref rid="tra12409-bib-0067" ref-type="ref">67</xref>. BDCPs are cytoplasmic, membraneâassociated proteins known to function in endolysosomal trafficking [reviewed in <xref rid="tra12409-bib-0068" ref-type="ref">68</xref>]. Although initially described as a transmembrane, mitochondrial protein <xref rid="tra12409-bib-0069" ref-type="ref">69</xref>, <xref rid="tra12409-bib-0070" ref-type="ref">70</xref>, TMHMM2.0 analysis of WDR81 showed no characteristic features of an integral membrane protein <xref rid="tra12409-bib-0071" ref-type="ref">71</xref>, and ultracentrifugation of cell homogenates did not support this assertion (Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>B). Indeed, ultracentrifugation of cell homogenates showed that WDR81 was predominantly found in the soluble fraction at neutral pH and entirely in the soluble fraction at high pH (Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>B). This suggests that WDR81 is a cytosolic protein which may associate with membranes.</p>
        <fig fig-type="Figure" xml:lang="en" id="tra12409-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>
<bold>WDR81 is a BEACH domain containing protein that associates with endolysosomal membranes.</bold> A) Schematic view of WDR81 and LYST protein domains. B) Ultracentrifugation of HeLa cell homogenates in neutral pH TBS buffer and highly basic sodium carbonate buffer. WCE, whole cell extract. C) Immunostaining of 2ÃHAâWDR81 and EEA1 or LAMP1 in cytosol extracted HeLa cells. WDR81KO cells complemented with exogenous 2xHAâWDR81 were permeabilized with saponin to extract nonâmembraneâassociated proteins and fixed before immunolabelling. Scale bars: 5 Âµm.</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="TRA-17-940-g002">
            <alt-text>TRA-12409-FIG-0003-c</alt-text>
          </graphic>
        </fig>
        <p id="tra12409-para-0018">We next sought to identify the compartment(s) with which WDR81 associates. Exogenous expression of 2ÃHAâWDR81 in WDR81KO cells rescues the accumulation of tetherin from enlarged perinuclear vesicles (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>F and G) but leads to significantly higher protein levels as compared to wildâtype cells (Figure <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>E) which limit subâcellular localization studies. Extraction of nonâmembraneâassociated proteins by a brief saponin wash prior to fixation allowed us to image the membrane bound fraction of 2ÃHAâWDR81. We found that membraneâassociated 2ÃHAâWDR81 partially colocalizes with both early EEA1 positive and late LAMP1 positive endocytic compartments (Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>C). The remaining WDR81 pool observed in Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>C probably reflects remaining cytosolic protein due to incomplete extraction and/or other membraneâassociated protein. Nevertheless, taken together, Figures <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>B and C suggest that WDR81 associates with endolysosomal membranes.</p>
      </sec>
      <sec id="tra12409-sec-0005">
        <title>WDR81 modulates endolysosomal morphology and the delivery of endocytosed cargo to late endoâlysosomal compartments</title>
        <p id="tra12409-para-0019">Because tetherin traffics through the endolysosomal pathway, we wanted to identify the site of tetherin accumulation in the absence of WDR81. Our prediction that the swollen tetherin positive vesicles seen in WDR81 knockout cells were enlarged endosomal and/or lysosomal compartments was confirmed by the accessibility of these vesicles to endocytosed, fluid phase dextran (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>A). To further characterize these swollen endolysosomal compartments in WDR81 depleted cells we examined the distribution of known endolysosomal markers. Confocal microscopy images showed that swollen compartments were positive for early endosomal markers (EEA1 and Rab5) (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>B) and late endosomal/lysosomal markers (CD63, LAMP1 and Cathepsin D) (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>C). Thus, WDR81 is required for maintaining the correct morphology of both early and late endocytic compartments.</p>
        <fig fig-type="Figure" xml:lang="en" id="tra12409-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>
<bold>WDR81 depletion alters endolysosomal morphology and trafficking, and promotes the accumulation of tetherin in swollen EEA1 positive vesicles.</bold> A) Confocal immunostaining of tetherin (red) in WDR81KO HeLa cells loaded with dextran Alexa Fluor 488 (green) for 16 h. BâC) Confocal microscopy images of early (B) and late (C) endolysosomal markers in control and WDR81KO HeLa cells. D) Confocal live microscopy of control and WDR81KO cells incubated with Magic Red. E) Confocal immunostaining of tetherin (red), EEA1 (green) and LAMP1 (blue) in WDR81 KO cells. F) Representative liveâcell confocal microscopy images of control, WDR81 and 2ÃHAâWDR81 complemented WDR81KO HeLa cells that had been loaded with dextran Alexa Fluor 488 (green) for 2 h, chased for 1 h and then stained with Magic Red (red). G) Quantification of colocalization of dextran Alexa Fluor 488 with Magic Red using images captured by liveâcell confocal microscopy of the cells in âFâ. Mean Â± SEM of three independent experiments with five fields each, â¥30 cells total per condition. *p â¤ 0.05. All scale bars represent 5 Âµm.</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="TRA-17-940-g005">
            <alt-text>TRA-12409-FIG-0004-c</alt-text>
          </graphic>
        </fig>
        <p id="tra12409-para-0020">Our findings of impaired tetherin degradation, together with the accumulation of tetherin in swollen endolysosomal compartments in the absence of WDR81 (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>D) questioned whether the loss of WDR81 affected lysosomal acidification or trafficking of lysosomal proteases such that the degradative capacity of the lysosomal compartment is impaired. Liveâcell confocal microscopy of LysoSensor Yellow/Blue DNDâ160 labelled WDR81KO cells showed that some of the swollen compartments were acidic (Figure S3A and quantified in B). The presence of both neutral and acidic swollen compartments is consistent with the idea that depletion of WDR81 causes the enlargement of both early (neutral) and late (acidic) endosomes. Quantification of yellow/blue ratios revealed that depletion of WDR81 causes higher acidification of late endosomal compartments (Figure S3B). Furthermore, swollen compartments were readily labelled by the membrane permeable, cresyl violetâconjugated Magic Red substrate for Cathepsin B (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>D). Together these experiments suggest that in the absence of WDR81, these swollen endolysosomal compartments are both acidified and contain functional lysosomal proteases.</p>
        <p id="tra12409-para-0021">Because the degradative capacity of late endolysosomal compartments appeared unimpaired in WDR81âdepleted cells, we predicted that tetherin accumulation should occur in early compartments. To test this, we fluorescently labelled both control and WDR81KO cells for tetherin together with the early endosomal marker EEA1 and/or the late endosomal/lysosomal marker LAMP1. In wildâtype HeLa cells, the intracellular pool of tetherin localizes predominantly within EEA1 positive vesicles [Figure S3C and <xref rid="tra12409-bib-0045" ref-type="ref">45</xref>] but not within LAMP1 positive vesicles (Figure S3D). In the absence of WDR81, the early EEA1 positive and late LAMP1 positive compartments are distinct and tetherin accumulation is predominantly seen within early, swollen EEA1 positive vesicles (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>E and S3C) but not within late, swollen LAMP1 positive vesicles (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>E and S3D).</p>
        <p id="tra12409-para-0022">Taken together, the data in Figures <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>D and <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>BâE suggest that WDR81 depletion abolishes maturation of endosomal compartments and/or impairs the delivery of cargo from early to late endolysosomal compartments. To examine this further we determined how loss of WDR81 affected the delivery of endocytosed fluorescent dextran to Magic Redâpositive, cathepsinâactive organelles using a published assay, previously used to show the requirement for mammalian homologs of the HOPS complex in delivery of endocytosed dextran to cathepsinâactive lysosomes <xref rid="tra12409-bib-0060" ref-type="ref">60</xref>, <xref rid="tra12409-bib-0061" ref-type="ref">61</xref>. Using the control, WDR81KO and rescued (2ÃHAâWDR81 complemented) HeLa cell lines described in Figures <xref rid="tra12409-fig-0002" ref-type="fig">2</xref>E and F, we observed a reproducible reduction in delivery of dextran to Magic Redâpositive organelles in WDR81KO HeLa cells, that was clearly rescued by expression of WDR81 cDNA (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>F and G). These data are consistent with a requirement for WDR81 in the maturation of endosomal compartments and/or an impairment in the delivery of cargo to late endolysosomal compartments.</p>
      </sec>
      <sec id="tra12409-sec-0006">
        <title>WDR81 depletion inhibits the degradation of EGFR by sequestering it in early endosomal compartments</title>
        <p id="tra12409-para-0023">Because the depletion of WDR81 affected endolysosomal maturation and the delivery of tetherin to late endolysosomes, we wanted to determine whether WDR81 depletion also affects the degradation of other cell surface proteins. We therefore examined the trafficking of the wellâcharacterized EGFR, which is phosphorylated upon EGF ligand binding, rapidly endocytosed and trafficked to lysosomes. The degradation of endocytosed EGFR was examined in control and WDR81KO HeLa cells by pulsing cells with EGF, chasing for the specified times and immunoblotting solubilized cells for phosphorylated EGFR (pEGFR) (Figure <xref rid="tra12409-fig-0005" ref-type="fig">5</xref>A). In WDR81âdepleted cells we observed a delay in the degradation of pEGFR (Figure <xref rid="tra12409-fig-0005" ref-type="fig">5</xref>B). In the absence of WDR81, delayed EGFR degradation was also observed using confocal microscopy of EGFâAlexa 555 pulsed cells (Figure S4).</p>
        <fig fig-type="Figure" xml:lang="en" id="tra12409-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>
<bold>WDR81 depletion delays EGFR degradation and promotes EGFR accumulation in early EEA1 positive endosomal compartments.</bold> A) Control, WDR81KO and bafilomycin A (400 n<sc>m</sc>) treated control cells were stimulated with EGF for the indicated times and analysed using immunoblot for phosphorylated EGFR (pEGFR). CNX, calnexin. B) pEGFR signal from three replicates of the experiment shown in âAâ was quantified using Image J, normalized by loading and the average normalized pEGFR levels from control and WDR81KO cells were plotted to reflect percentage of normalized pEGFR at 45 min Â±SEM. C) Confocal microscopy of control and WDR81KO HeLa cells stimulated with EGFâAlexaâ555 for 5 min (red) and chased for the indicated times. Cells were then fixed and stained for EEA1 (green). Scale bars represent 10 Âµm. D) Quantification of colocalization (normalized to the 20 min time point) of EGFâAlexaâ555 with EEA1 using images captured by liveâcell confocal microscopy of the cells in âCâ. Mean Â± SEM of three independent experiments with â¥5 fields (average two cells per field) each per condition. Scale bars represent 5 Âµm.</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="TRA-17-940-g008">
            <alt-text>TRA-12409-FIG-0005-c</alt-text>
          </graphic>
        </fig>
        <p id="tra12409-para-0024">Having shown that in WDR81KO cells tetherin accumulates in early EEA1 positive endosomal compartments (Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>E and S3C), we next asked whether the delay in EGFR degradation seen in WDR81KO cells (Figure <xref rid="tra12409-fig-0005" ref-type="fig">5</xref>A and B) is due to EGFR accumulation in EEA1 positive endosomes. An accumulation of EGFâAlexaâ555 bound EGFR in EEA1 positive compartments was seen in WDR81âdepleted cells (Figure <xref rid="tra12409-fig-0005" ref-type="fig">5</xref>C and D), consistent with a defect in exit from EEA1 positive endosomes. Taken together, Figure <xref rid="tra12409-fig-0004" ref-type="fig">4</xref>E, S3C, 5C and D suggest that depletion of WDR81 delays exit of endocytosed cargo from early endosomal compartments.</p>
      </sec>
      <sec id="tra12409-sec-0007">
        <title>WDR81 function is dependent on interaction with WDR91</title>
        <p id="tra12409-para-0025">To determine if WDR81 acts alone, or in complex with other proteins, we used immunoprecipitation and mass spectrometry to identify binding partners of WDR81. Immunoprecipitation of HAâtagged WDR81 from WDR81 knockout HeLa cells complemented with 2ÃHAâWDR81 was performed. After subtracting proteins also present in control immunoprecipitates, WDR91 was identified as a WDR81 interaction partner (with 12 unique peptides, Figure <xref rid="tra12409-fig-0006" ref-type="fig">6</xref>A). WDR91 is a 747 amino acid protein whose bioinformatic analysis revealed 7 Câterminal WD40 domains. To determine whether the interaction between WDR81 and WDR91 was of functional importance we used the CRISPRâCas9 system and three WDR91 sgRNAs to generate independent WDR91 deficient cell lines. In each of these cell lines, we observed accumulation of tetherin in swollen endolysosomes, identical to those seen following depletion of WDR81 (Figure <xref rid="tra12409-fig-0006" ref-type="fig">6</xref>B). The depletion of WDR81 together with WDR91 did not exacerbate tetherin accumulation (Figure <xref rid="tra12409-fig-0006" ref-type="fig">6</xref>C). Furthermore, we observed enlargement of both early EEA1 positive and late LAMP1 positive endolysosomal compartments in WDR91 depleted cells (Figure <xref rid="tra12409-fig-0006" ref-type="fig">6</xref>D), as seen in WDR81KO cells. Interestingly, a Câterminal GFP fusion, which rendered an exogenous WDR81 construct nonâfunctional (i.e. unable to rescue tetherin accumulation in WDR81KO cells, Figure S5A), was unable to bind WDR91 (Figure S5B). Taken together, the data shown in Figures <xref rid="tra12409-fig-0006" ref-type="fig">6</xref> and S5 suggest that interaction of WDR81 and WDR91 is critical for function.</p>
        <fig fig-type="Figure" xml:lang="en" id="tra12409-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>
<bold>WDR81 forms a functional complex with WDR91.</bold> A) Mass spectrometry analysis of 2ÃHAâWDR81 immunoprecipitates from 2ÃHAâWDR81 expressing HeLa cells as compared with wildâtype control HeLa cells identifies WDR91 as a WDR81 binding partner. B) WDR91 was depleted in HeLa cells by stable expression of Cas9 and three independent WDR91âspecific sgRNAs. Tetherin trafficking in the resulting WDR91 KO cell lines and controls was analysed using confocal immunostaining. Scale bars represent 10 Âµm. C) WDR91 was depleted in WDR81KO clones and tetherin distribution was imaged using confocal microscopy. Scale bars represent 10 Âµm. D) Confocal microscopy images of early EEA1 positive and late LAMP1 positive endolysosomal compartments in control and WDR91 depleted HeLa cells. Scale bars represent 5 Âµm.</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="TRA-17-940-g006">
            <alt-text>TRA-12409-FIG-0006-c</alt-text>
          </graphic>
        </fig>
      </sec>
    </sec>
    <sec id="tra12409-sec-0008">
      <title>Discussion</title>
      <p id="tra12409-para-0026">In this study, our forward genetic screen identified a requirement for WDR81 in the HIVâVpuâmediated degradation of tetherin. Subsequent experiments showed that WDR81 may play a more general role in the degradation of internalized PM proteins, that is independent of HIVâVpu. The degradation of both tetherin and pEGFR was delayed in WDR81âdepleted cells with both tetherin and EGFR accumulating in enlarged, early, EEA1 positive endosomes. WDR81 associates with both early and late endolysosomal compartments and the loss of WDR81 affected the morphology of the endolysosomal pathway with the appearance of swollen early and late compartments. This was accompanied by impaired delivery of fluid phase dextran cargo to cathepsinâactive lysosomes. Nevertheless, lysosomes of WDR81âdepleted cells were able to acidify and contained functional lysosomal proteases. We also found that WDR81 forms a complex with WDR91, which is required for correct function of these proteins. Our data suggest that the WDR81âWDR91 complex is required for the trafficking and degradation of internalized PM proteins and facilitates delivery of cargo from early to late endosomal/lysosomal compartments. Our findings are consistent with a recent report from Liu et al. <xref rid="tra12409-bib-0072" ref-type="ref">72</xref>, published during preparation of our manuscript, which identified the <italic>Caenorhabditis elegans</italic> orthologues of WDR81 and 91 (respectively F25C9.1 or SORFâ2 and ZK563.5 or SORFâ1), as genes required for partial rescue of the endosome/lysosome fusion defects present in coelomocytes of <italic>C. elegans vps18</italic> mutants and showed that mammalian WDR81 and WDR91 form a complex functioning in endolysosomal trafficking.</p>
      <p id="tra12409-para-0027">The development of forward genetic screens in haploid human cells <xref rid="tra12409-bib-0073" ref-type="ref">73</xref> provides a powerful approach to dissect cellular pathways in mammalian systems. Initially used in lethality screens <xref rid="tra12409-bib-0052" ref-type="ref">52</xref>, <xref rid="tra12409-bib-0073" ref-type="ref">73</xref>, <xref rid="tra12409-bib-0074" ref-type="ref">74</xref>, this approach has more recently been applied to the selection of either cell surface or intracellular phenotypes <xref rid="tra12409-bib-0053" ref-type="ref">53</xref>, <xref rid="tra12409-bib-0054" ref-type="ref">54</xref>, <xref rid="tra12409-bib-0055" ref-type="ref">55</xref>, <xref rid="tra12409-bib-0075" ref-type="ref">75</xref>, and was used here to identify components of the endocytic machinery. To effectively enrich for the desired cellular phenotype may require at least two FACS selections and is therefore dependent on preserving cell viability throughout the timescale of the selection process, which may be up to 28 days. HIVâVpu degrades CD4 from the early secretory pathway via the cellular ERAD machinery, while degradation of tetherin and SNAT1 occurs in the late secretory pathway. Our genetic approach was successful in identifying critical host cell components, including the E3 ligase Î²TrCP2, required for Vpuâmediated CD4 downregulation, but the identification of cellular genes required for Vpuâmediated downregulation of tetherin proved more challenging as the cells only survived a single round of positive FACSâselection. The reasons for this are not entirely clear, but suggest that cells may be less tolerant of perturbations in the late as compared with the early secretory pathway.</p>
      <p id="tra12409-para-0028">Despite the selection for tetherin<sup>high</sup>âexpressing cells only surviving a single enrichment, our screen identified four significant genes which function in the endocytic pathway (Figure <xref rid="tra12409-fig-0001" ref-type="fig">1</xref>B). VPS33a and VPS39 are components of the HOPS complex <xref rid="tra12409-bib-0056" ref-type="ref">56</xref>, <xref rid="tra12409-bib-0057" ref-type="ref">57</xref>, <xref rid="tra12409-bib-0058" ref-type="ref">58</xref>, which function in endosomal maturation <xref rid="tra12409-bib-0059" ref-type="ref">59</xref>, delivery of cargo to lysosomes <xref rid="tra12409-bib-0060" ref-type="ref">60</xref>, <xref rid="tra12409-bib-0061" ref-type="ref">61</xref> and fusion of autophagosomes with late endosomes/lysosomes <xref rid="tra12409-bib-0062" ref-type="ref">62</xref>, and are therefore promising candidates for interference with tetherin downregulation and degradation. Furthermore, siRNAâmediated depletion of the HOPS components VPS33a <xref rid="tra12409-bib-0076" ref-type="ref">76</xref> and VPS41 <xref rid="tra12409-bib-0077" ref-type="ref">77</xref>, <xref rid="tra12409-bib-0078" ref-type="ref">78</xref> impairs degradation of EGFR.</p>
      <p id="tra12409-para-0029">We focussed on the top hit of our screen, as WDR81 is a poorly characterized protein and one of nine BEACH domain containing proteins (BDCP) [reviewed in <xref rid="tra12409-bib-0068" ref-type="ref">68</xref>]. The BEACH domain was initially identified as a conserved region within LYST but its exact function remains unclear. Unlike other BDCPs which have a Câterminus proximal BEACH domain preceded by a pleckstrin homology (PH) domain, the BEACH domain of WDR81 is close to the Nâterminus with no predicted PH domain (Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>A). As its name implies, WDR81 has multiple WD40 repeat (WDR) domains known to form scaffolds on which large protein complexes assemble [reviewed in <xref rid="tra12409-bib-0079" ref-type="ref">79</xref>, <xref rid="tra12409-bib-0080" ref-type="ref">80</xref>]. Although WDR81 was earlier suggested being an integral membrane spanning protein <xref rid="tra12409-bib-0069" ref-type="ref">69</xref>, both our bioinformatic and biochemical (Figure <xref rid="tra12409-fig-0003" ref-type="fig">3</xref>B) analysis suggest that WDR81 is cytosolic and it associates with EEA1 positive and LAMP1 positive endosomal membranes. This is in agreement with the recent findings of Liu et al. <xref rid="tra12409-bib-0072" ref-type="ref">72</xref> who showed the association/colocalization of WDR81 with EEA1â and Rab7âpositive endosomes.</p>
      <p id="tra12409-para-0030">The depletion of WDR81 led to only a modest increase in cell surface tetherin, but a marked accumulation of intracellular tetherin that was apparent in both Vpuâsufficient and Vpuâdeficient cells. Taken together, our results suggest that this is due to a perturbation in delivery of endocytosed cargo to lysosomes caused by accumulation of cargo in early endosomal compartments. The recent findings of Liu et al. <xref rid="tra12409-bib-0072" ref-type="ref">72</xref> provide important mechanistic insight into our own observations on the defect of tetherin trafficking and degradation seen in WDR81â and WDR91âdepleted cells. They showed that WDR81 and WDR91 were able to regulate phosphatidylinositol 3âphosphate (PtdIns3P) levels on endosomal membranes. Consequently, depletion of WDR81 and WDR91 led to the accumulation of PtdIns3P on early endosomal membranes, which caused excessive fusion of early endosomes and delayed earlyâtoâlate endosome conversion <xref rid="tra12409-bib-0072" ref-type="ref">72</xref>. Indeed, delayed trafficking of endocytosed fluid phase markers and altered endolysosomal morphology with enlarged early and late endolysosomal compartments was observed in WDR81âdepleted mammalian cells [present study and <xref rid="tra12409-bib-0072" ref-type="ref">72</xref>] as well as in F25C9.1 (WDR81 ortholog) depleted <italic>C. elegans</italic> coelomocytes, suggesting that this phenotype is evolutionarily conserved from <italic>C. elegans</italic> to humans. Although Liu et al. also observed that the WDR81âWDR91 complex interacts with Beclin1 to inhibit the phosphatidylinositol 3âkinase complex <xref rid="tra12409-bib-0072" ref-type="ref">72</xref>, we did not detect Beclin1 in our WDR81 mass spec IP suggesting that this interaction might be relatively weak.</p>
      <p id="tra12409-para-0031">Mutations in several BDCPs cause human disease [reviewed in <xref rid="tra12409-bib-0068" ref-type="ref">68</xref>] and WDR81 is no exception. The P856L mutation in WDR81 is associated with cerebellar ataxia, mental retardation, and disequilibrium syndrome 2 (CAMRQ2) <xref rid="tra12409-bib-0069" ref-type="ref">69</xref>. It would therefore be interesting to determine whether this mutation causes the same phenotype as WDR81 depletion or whether P856L acts as a gain of function mutation. Because the mutation occurs in the central region of WDR81, further studies should aim to identify whether it abolishes binding to WDR91.</p>
      <p id="tra12409-para-0032">In summary, we have shown a critical role for the WDR81âWDR91 complex in facilitating endosomal maturation and delivery of cargo to late endolysosomes. Furthermore, our results provide evidence for the role of the WDR81âWDR91 complex in facilitating the downregulation and subsequent degradation of cell surface receptors.</p>
    </sec>
    <sec id="tra12409-sec-0009">
      <title>Materials and Methods</title>
      <sec id="tra12409-sec-0010">
        <title>Plasmids</title>
        <p id="tra12409-para-0033">Codon optimized NL4â3 Vpu was subcloned from pCR3.1âVpuâHA <xref rid="tra12409-bib-0038" ref-type="ref">38</xref> into the lentiviral expression vector pHRSINâRoxâP<sub>SFFV</sub>âGFPâP<sub>PGK</sub>âpuromycin<sup>R</sup>âRox <xref rid="tra12409-bib-0054" ref-type="ref">54</xref> in place of the GFP. The resulting plasmid was further modified downstream of Vpu with an internal ribosome entry site (IRES) CFP to generate the pHRSINâRoxâP<sub>SFFV</sub>âVpuâIRESâCFPâP<sub>PGK</sub>âpuromycin<sup>R</sup>âRox expression vector.</p>
        <p id="tra12409-para-0034">C terminally GFP tagged WDR81 was subcloned from the pCS2âWDR81âGFP construct (Creative Biogene) into the pHRSINâP<sub>PGK</sub>âblasticidin<sup>R</sup> background to generate pHRSINâP<sub>SFFV</sub>âWDR81âGFPâP<sub>PGK</sub>âblasticidin<sup>R</sup>. The construct was further modified to accommodate a double HA tag at the N terminus of WDR81 thus generating pHRSINâP<sub>SFFV</sub>â2xHAâWDR81âP<sub>PGK</sub>âblasticidin<sup>R</sup>.</p>
        <p id="tra12409-para-0035">
<italic>Streptococcus pyogenes</italic> Cas9 was subcloned from the PX458 plasmid [Addgene; created by Feng Zhang, Massachusetts Institute of Technology, Boston, MA <xref rid="tra12409-bib-0081" ref-type="ref">81</xref>] into a pHRSIN backbone creating pHRSINâP<sub>SFFV</sub>âFLAGâNLSâCas9âNLSâP<sub>PGK</sub>âhygromycin<sup>R</sup>. Short guide RNAs (sgRNA) were expressed from the pKLVâU6gRNA(BbsI)âPGKpuro2ABFP plasmid [Addgene; created by Kosuke Yusa, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK <xref rid="tra12409-bib-0082" ref-type="ref">82</xref>] targeting WDR81 and WDR91, respectively. Specific sgRNA sequences used: WDR81 sgRNA#1 5â²âAGGTGGCCACGGGCTCGCTCâ3â² (exon 5); WDR81 sgRNA#2 5â²âCCTCATGGCTGATCCGGGGCâ3â² (exon 4); WDR91 sgRNA#1 5â²âCAGCTCGTCAGTGCGCTCCAâ3â² (exon 1); WDR91 sgRNA#2 5â²âGTAGCTCCAATAATCCCGAAâ3â² (exon 2); WDR91 sgRNA#3 5â²âGTCTGTATATATCCTCCAAGâ3â² (exon 2); All plasmids were sequenced by Source Bioscience.</p>
      </sec>
      <sec id="tra12409-sec-0011">
        <title>Cell lines</title>
        <p id="tra12409-para-0036">KBM7, CEMT4 and HeLa cells were maintained in IMDM supplemented with 10% foetal calf serum and penicillin/streptomycin. Stable cell lines were produced by lentivirus transduction. Lentivirus was produced by cotransfecting 293ET cells with lentiviral vectors along with the packaging plasmids pCMVÎR8.91 and pMD.G using TransITâ293 (Mirus) according to the manufacturer's instructions. Viral supernatant was harvested 48 h postâtransfection, filtered and transferred to cells, followed by spin infection at 1800 rpm for 45 min.</p>
      </sec>
      <sec id="tra12409-sec-0012">
        <title>Antibodies</title>
        <p id="tra12409-para-0037">Mouse antiâTetherin (APC coupled, BioLegend, 348410) and mouse antiâCD4 (PE coupled, BioLegend, 300508) were used for flowâcytometry and FACS. Antibodies used for immunoblotting include: rabbit antiâWDR81 (Abcam, ab1217333, LOT GR98370â3); rabbit antiâTetherin [NIH AIDS Reagent Programme, 11721, LOT 110114, <xref rid="tra12409-bib-0083" ref-type="ref">83</xref>]; rabbit antiâPhosphoâEGF Receptor (Cell Signalling, 2234); mouse antiâMHCâI heavy chain (clone 3B10.7); mouse antiâFatty Acid Synthase (BD, 610962); mouse antiâÎ±âtubulin (Sigma, T9026); mouse antiâÃâactin (Sigma, A2228); mouse antiâcalnexin (BD, 610962); goat antiâmouseâHRP (Jackson ImmunoResearch, 115â035â062) and goat antiârabbitâHRP (Jackson ImmunoResearch, 111â035â144). Antibodies used for confocal microscopy: rabbit antiâTetherin [NIH AIDS Reagent Programme, 11721, LOT 110114, <xref rid="tra12409-bib-0083" ref-type="ref">83</xref>]; mouse antiâHA (BioLegend, 901502); mouse antiâEEA1 (BD, 610457); mouse antiâRab5 (BD, 610724); mouse antiâCD63 (BD, 556019); mouse antiâLAMP1 (BD, 555798); mouse antiâLAMP1 (Alexa Fluor 647 conjugated, BD, 562622); rabbit antiâCathepsin D (Millipore, 219361); donkey antiârabbit IgG (Alexa Fluor 488 conjugate, Thermo Fisher Scientific, Aâ21206); donkey antiâmouse IgG (Alexa Fluor 647 conjugate, Thermo Fisher Scientific, Aâ31571); goat antiâmouse IgG (Pacific Blue conjugate, Thermo Fisher Scientific, P31582).</p>
      </sec>
      <sec id="tra12409-sec-0013">
        <title>Haploid genetic screen</title>
        <p id="tra12409-para-0038">The screen followed previously described protocols <xref rid="tra12409-bib-0053" ref-type="ref">53</xref> with a number of adjustments. Firstly, to avoid potential artefacts associated with single proviral integration sites, we pooled three VpuâIRESâCFP KBM7 clones that express low PM levels of both Tetherin and CD4 and expanded them to 100 million cells prior to mutagenesis. The geneâtrap vector used resembles the previously described pGTâGFPâpA <xref rid="tra12409-bib-0075" ref-type="ref">75</xref>, with the exception of a loxP cassette which was subcloned into the 3â² LTR. One week postâmutagenesis, cells were selected for either Tetherin<sup>high</sup> or CD4<sup>high</sup>. The collected CD4<sup>high</sup> population was subjected to a second enrichment prior to genomic DNA extraction. For the tetherin<sup>high</sup> screen, genomic DNA was extracted from the cells recovered after the first sort. Geneâtrap integration sites were mapped and processed as previously described <xref rid="tra12409-bib-0053" ref-type="ref">53</xref>.</p>
      </sec>
      <sec id="tra12409-sec-0014">
        <title>Flow cytometry</title>
        <p id="tra12409-para-0039">Cells were washed in PBS and, if necessary, detached by trypsinization. Routinely, 5 Ã 10<sup>5</sup> cells were incubated for 30 min at 4Â°C in 100 Î¼L PBS with the indicated fluorochromeâconjugated antibody or stained sequentially with primary and fluorochromeâconjugated secondary antibodies. Following fixation with 4% paraformaldehyde (PFA), cells were analysed on a Fortessa (BD). Data were analysed with the FlowJo software.</p>
      </sec>
      <sec id="tra12409-sec-0015">
        <title>CRISPR/Cas9âmediated gene disruption</title>
        <p id="tra12409-para-0040">Cells stably expressing Cas9 and WDR81 or WDR91 specific sgRNAs were created by cotransfection of Cas9, sgRNA plasmids and packaging plasmids in 293ET, following the same protocol used for the generation of stable cell lines. WDR81 depletions by transient Cas9 and sgRNA expression were generated by cotransfecting HeLa cells with the Cas9 and WDR81 sgRNA#1 plasmids using TransITâHeLaMONSTER (Mirus) according to the manufacturer's instructions. After 24 h of transfection, cells were enriched for 72 h by puromycin and hygromycin selection and then single cell cloned. WDR81 knockout clones were identified using Immunoblot.</p>
      </sec>
      <sec id="tra12409-sec-0016">
        <title>Immunoblotting</title>
        <p id="tra12409-para-0041">Cells were washed in PBS and, if necessary, detached by trypsinization and lysed in 1% Triton Xâ100 in TBS with 0.5 m<sc>m</sc> phenylmethylsulfonyl fluoride (PMSF), 10 m<sc>m</sc> iodoacetamide (IAA), and Roche complete protease inhibitor for 30 min on ice. Postânuclear supernatants were heated at 40Â°C for 20 min in SDS sample buffer, separated by SDSâPAGE, and proteins transferred to PVDF membranes (Milipore). Membranes were blocked in 5% milk (Marvel) in PBS/0.2% Tween and probed with the indicated antibodies. Reactive bands were visualized using SuperSignal West Pico chemiluminescent substrate (Thermo Fisher Scientific). To quantitate protein levels, Xâray films were scanned and subjected to densitometric analysis using ImageJ. Signal was then normalized by exposure and loading control prior to plotting on bar charts. Error bars represent the SEM for three technical repeats. Statistical significance was evaluated by paired, twoâtailed <italic>t</italic>âtests.</p>
      </sec>
      <sec id="tra12409-sec-0017">
        <title>Confocal microscopy</title>
        <p id="tra12409-para-0042">Cells were grown overnight on round 13 mm glass coverslips, fixed in 4% PFA and permeabilized with 0.5% Triton Xâ100, each step followed by two PBS washes. Where indicated, HeLa cytosol was extracted by incubating cells for 40 second in PBS containing 0.05% saponin and then immediately formaldehyde fixed. Cells were then blocked for 30 min with 5% FCS in PBS and incubated with primary antibody for 45â60 min at room temperature. Following three washes in blocking buffer, fluorescently coupled secondary antibody was applied for 30 min. After three washes in blocking buffer and three washes in water, coverslips were mounted in ProLong Gold Antifade Mountant with DAPI (Thermo Fisher Scientific) and imaged on a Zeiss LSM880 Confocal Microscope. Images were processed using the Zen 2011 software (Zeiss).</p>
      </sec>
      <sec id="tra12409-sec-0018">
        <title>EGFR degradation assay</title>
        <p id="tra12409-para-0043">For quantification by immunoblot, cells were incubated in HBSS amino acid depleted media (Thermo Fisher Scientific, 24020117) with 10 Âµg/mL cycloheximide and, where indicated, with 400 n<sc>m</sc> bafilomycin A (SigmaâAldrich) for 1 h prior to continuous stimulation with EGF (100 ng/mL) for the indicated times. Cells were then lysed and processed as described above. Three experimental repeats were subjected to densitometric analysis using the ImageJ software. The resulting plot was adjusted to reflect mean percentage of normalized pEGFR levels at 45 min Â± SEM.</p>
        <p id="tra12409-para-0044">For visualization of endocytosed EGFR by confocal microscopy, cells seeded on cover slips were amino acid starved for 1 h prior to a 5 min incubation with EGFâAlexaâ555 (Thermo Fisher Scientific, Eâ35350) on ice. Cells were then washed twice in cold PBS and incubated at 37Â°C for the indicated times. Cells were then fixed in 4% PFA, washed, EEA1 stained and mounted. Single confocal images were acquired as described above (three independent experiments with â¥5 fields each per condition, average of two cells per field, randomly selected). The degree of colocalization between EGFâAlexaâ555 and EEA1 was measured by Manders M1/M2 colocalization coefficients using the ZEN 2011 software (Zeiss) and normalized to the 20 min time point. Peak colocalization between EEA1 and EGFR was previously reported at 15 min <xref rid="tra12409-bib-0084" ref-type="ref">84</xref>, <xref rid="tra12409-bib-0085" ref-type="ref">85</xref>. In this study, we incubated a further 5 min at 37Â°C (total 20 min) to allow cells to equilibrate after pulsing on ice.</p>
      </sec>
      <sec id="tra12409-sec-0019">
        <title>Dextran, Magic Red and Lysosensor labelling</title>
        <p id="tra12409-para-0045">To label the endocytic pathway with dextran, cells were loaded for 16 h with 1 mg/mL dextran Alexa Fluor 488 10 000 MW, anionic (Thermo Fisher Scientific, Dâ22910), washed, fixed, permeabilized and stained for intracellular tetherin as described above. To label endosomal/lysomal compartments containing the active acid hydrolase cathepsin B, live cells on coverslips were incubated for 5 min at 37Â°C with Magic Red MRâ(RR)<sub>2</sub> Cathepsin B substrate (1:2600 dilution) (ImmunoChemistry Technologies, 938) and then imaged on an incubated Zeiss LSM710 Confocal Microscope. To assess acidic organelles, cells were labelled with LysoSensor Yellow/Blue DNDâ160 (Thermo Fisher Scientific, Lâ7545), a ratiometric probe that produces blue fluorescence in a neutral environment but shifts to yellow fluorescence in more acidic compartments (pKa â 4.2). Cells were incubated for 1 min at 37Â°C with LysoSensor and then imaged on an incubated Zeiss LSM710 Confocal Microscope. Cells were excited at 405 nm and images were taken at 455.5 Â± 32.5 and 570.5 Â± 70.5 nm of emission. Zen 2011 (Zeiss) and ImageJ software were used for the analysis and processing of confocal images. The graph shows the mean value with the standard error mean of the yellow/blue ratios obtained from three experimental repeats (20 cells spread across 4 confocal fields for each experimental condition).</p>
      </sec>
      <sec id="tra12409-sec-0020">
        <title>Delivery of endocytosed dextran to lysosomes</title>
        <p id="tra12409-para-0046">A previously described protocol was used to measure the delivery of endocytosed dextran to lysosomes by quantitative live cell confocal microscopy <xref rid="tra12409-bib-0061" ref-type="ref">61</xref>. Briefly, HeLa cells were loaded for 2 h with 1 mg/mL Dextran Alexa Fluor 488 10 000 MW, anionic, fixable (Thermo Fisher Scientific) and then chased for 1 h in dextranâfree IMDM. Cells were then washed in PBS and incubated with Magic Red MRâ(RR)2 Cathepsin B substrate (1:2600 dilution) (ImmunoChemistry Technologies). Single confocal images were acquired using an incubated Zeiss LSM710 Confocal Microscope (three independent experiments with â¥5 fields each per condition, average of 1â2 cells per field, randomly selected). The degree of colocalization between Dextran Alexa Fluor 488 and Magic Red was measured by Manders M1/M2 colocalization coefficients using the ZEN 2011 software (Zeiss).</p>
      </sec>
      <sec id="tra12409-sec-0021">
        <title>Immunoprecipitation and mass spectrometry</title>
        <p id="tra12409-para-0047">Cells were lysed in 1% Triton Xâ100 or 1% NPâ40 in TBS with 0.5 m<sc>m</sc> PMSF, 10 m<sc>m</sc> IAA and Roche complete protease inhibitor for 30 min on ice. Postânuclear supernatants were preâcleared with protein A and IgGâSepharose (SigmaâAldrich) and incubated with EZview Red AntiâHA Affinity Gel (SigmaâAldrich) or antiâGFP (Roche, 11814460001) plus protein A sepharose for 4 h at 4Â°C. Following one wash in 1% and four washes in 0.5% lysis buffer, immunoprecipitated proteins were eluted in Lamelli buffer. Samples were then resolved by SDSâPAGE, gel lanes were excised and proteins were digested inâgel. Tryptic peptides were analysed by LCMS/MS and the raw files processed in Proteome Discoverer 1.4. Data were searched using Mascot against the Human Uniprot database including common contaminants and a randomised reverse database. Results were filtered to a PSM FDR of 1%.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data" id="tra12409-supitem-0001">
        <caption>
          <p id="tra12409-para-0001">
<bold>Figure S1. Haploid genetic screen is validated by the identification of components of the SCF<sup>Î²TrCP2</sup> E3 ubiquitin ligase complex, known to be required for Vpuâmediated downregulation of CD4 and degradation of CD4 and tetherin.</bold> A) Schematic view of the Vpu IRES CFP construct. B) Schematic of sorting gates designed to avoid selection of rare cells that have lost Vpu expression (shown inside the yellow dashed oval). C) Bubble plot illustrating the hits from the CD4<sup>high</sup> screen. Bubble size is proportional to the number of independent inactivating geneâtrap integrations identified (shown in brackets). DâE) Cytofluorometric analysis of tetherin and CD4 in control, Vpu expressing and Vpu expressing Î²TrCP2/1 depleted KBM7s (D) and CEMT4 (E) cells.</p>
          <p id="tra12409-para-0002">
<bold>Figure S2: Cell surface tetherin levels are partially rescued by WDR81 depletion in CEMT4 and HeLa cells.</bold> A) Cytofluorometric analysis of cell surface tetherin expression in CEMT4 T cells: wildâtype (WT â blue dotted histogram), Vpuâexpressing (Vpu â red dotted histogram) and Vpuâexpressing CEMT4 cells depleted of WDR81 (KO â orange shaded histograms) by stable expression of two independent sgRNAs. Number in black represents median fluorescence signal. B) Median plasma membrane tetherin signal from three independent experiments using cells in âAâ was plotted Â± SEM. * p â¤ 0.05. C) Cytofluorometric analysis of cell surface tetherin expression in HeLa cells: wildâtype (WT â blue dotted histogram), Vpu expressing (Vpu â red dotted histogram) and Vpuâexpressing HeLa cells depleted of WDR81 (KO â orange shaded histogram). Number in black represents median fluorescence signal. D) Immunostaining of tetherin in wildâtype and Vpuâexpressing HeLa cells. Showing the same images as in Figure 2D (left panels) with increased contrast in the tetherin channel. Processed with ZEN 2011. Scale bars represent 10 Âµm.</p>
          <p id="tra12409-para-0003">
<bold>Figure S3: Depletion of WDR81 does not impede endolysosomal acidification. Tetherin accumulates in early EEA1 positive but not in late LAMP1 positive compartments.</bold> A) Control and WDR81KO cells were labelled with LysoSensor Yellow/Blue DNDâ160, a ratiometric probe that produces blue fluorescence in a neutral environment (green) but shifts to yellow fluorescence in more acidic compartments (red). B) Averages of yellow/blue ratios obtained from three experimental repeats (20 cells spread across 4 confocal fields for each experimental condition) were plotted Â± SEM. **p â¤ 0.01. C) Immunostaining of tetherin and EEA1 in control and WDR81KO cells. D) Immunostaining of tetherin and LAMP1 in control and WDR81KO cells. All scale bars represent 5 Âµm.</p>
          <p id="tra12409-para-0004">
<bold>Figure S4: WDR81 depletion delays EGFR degradation.</bold> Confocal microscopy of control and WDR81KO HeLa cells stimulated with EGFâAlexa 555 and chased for the indicated times. Detector gain was decreased 1.25âfold for the 20, 60 and 180 min time points (as compared to 0 min). Scale bars represent 10 Âµm.</p>
          <p id="tra12409-para-0005">
<bold>Figure S5: Câterminal GFP fusion rendered an exogenous WDR81 construct nonâfunctional and unable to bind WDR91.</bold> A) Immunostaining of tetherin in WDR81âGFP complemented WDR81KO cells. Scale bars represent 10 Âµm. B) Mass spectrometric analysis of WDR81âGFP immunoprecipitates. Wildâtype HeLa cells were used as control.</p>
        </caption>
        <media xlink:href="TRA-17-940-s001.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="tra12409-sec-0022">
      <title>Acknowledgments</title>
      <p id="tra12409-para-0048">We are grateful to CIMR core facilities: R. Schulte and his team for FACS and M. Gratian and M. Bowen for microscopy. This work was supported by the Wellcome Trust, through a Principal Research Fellowship to PJL (084957/Z/08/Z) and PhD studentship to RR (079895/Z/06/Z), by MRC research grant MR/M010007/1 to J. P. L. and by a BBSRC industrial CASE studentship with G. S. K. Research and Development Ltd to L. J. D. The CIMR is in receipt of a Wellcome Trust strategic award 100140.</p>
    </ack>
    <ref-list content-type="cited-references" id="tra12409-bibl-0001">
      <title>References</title>
      <ref id="tra12409-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0001">
<string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Zang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bieniasz</surname>
<given-names>PD</given-names>
</string-name>. <article-title>Tetherin inhibits retrovirus release and is antagonized by HIVâ1 Vpu</article-title>. <source>Nature</source>
<year>2008</year>;<volume>451</volume>:<fpage>425</fpage>â<lpage>430</lpage>.<pub-id pub-id-type="pmid">18200009</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0002">
<string-name>
<surname>Van Damme</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Goff</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Katsura</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jorgenson</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Mitchell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Stephens</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>J</given-names>
</string-name>. <article-title>The interferonâinduced protein BSTâ2 restricts HIVâ1 release and is downregulated from the cell surface by the viral Vpu protein</article-title>. <source>Cell Host Microbe</source>
<year>2008</year>;<volume>3</volume>:<fpage>245</fpage>â<lpage>252</lpage>.<pub-id pub-id-type="pmid">18342597</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0003">
<string-name>
<surname>Kuhl</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Banning</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Marzi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Votteler</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Steffen</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bertram</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Glowacka</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Konrad</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sturzl</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Schubert</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Feldmann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Behrens</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Schindler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pohlmann</surname>
<given-names>S</given-names>
</string-name>. <article-title>The Ebola virus glycoprotein and HIVâ1 Vpu employ different strategies to counteract the antiviral factor tetherin</article-title>. <source>J Infect Dis</source>
<year>2011</year>;<volume>204</volume>(<issue>Suppl. 3</issue>):<fpage>S850</fpage>â<lpage>S860</lpage>.<pub-id pub-id-type="pmid">21987761</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0004">
<string-name>
<surname>Jouvenet</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Zhadina</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kratovac</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>McNatt</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hatziioannou</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bieniasz</surname>
<given-names>PD</given-names>
</string-name>. <article-title>Broadâspectrum inhibition of retroviral and filoviral particle release by tetherin</article-title>. <source>J Virol</source>
<year>2009</year>;<volume>83</volume>:<fpage>1837</fpage>â<lpage>1844</lpage>.<pub-id pub-id-type="pmid">19036818</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0005">
<string-name>
<surname>Kong</surname>
<given-names>WS</given-names>
</string-name>, <string-name>
<surname>Irie</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kawabata</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kadoi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sakaguchi</surname>
<given-names>T</given-names>
</string-name>. <article-title>Inhibition of virusâlike particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BSTâ2</article-title>. <source>Hiroshima J Med Sci</source>
<year>2012</year>;<volume>61</volume>:<fpage>59</fpage>â<lpage>67</lpage>.<pub-id pub-id-type="pmid">23077864</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0006">
<string-name>
<surname>Mansouri</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Viswanathan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Douglas</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Hines</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gustin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Moses</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Fruh</surname>
<given-names>K</given-names>
</string-name>. <article-title>Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcomaâassociated herpesvirus</article-title>. <source>J Virol</source>
<year>2009</year>;<volume>83</volume>:<fpage>9672</fpage>â<lpage>9681</lpage>.<pub-id pub-id-type="pmid">19605472</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0007">
<string-name>
<surname>Pan</surname>
<given-names>XB</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Cong</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>L</given-names>
</string-name>. <article-title>BST2/tetherin inhibits dengue virus release from human hepatoma cells</article-title>. <source>PLoS One</source>
<year>2012</year>;<volume>7</volume>:<fpage>e51033</fpage>.<pub-id pub-id-type="pmid">23236425</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0008">
<string-name>
<surname>Pardieu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vigan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Calvi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bieniasz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kellam</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Towers</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>The RINGâCH ligase K5 antagonizes restriction of KSHV and HIVâ1 particle release by mediating ubiquitinâdependent endosomal degradation of tetherin</article-title>. <source>PLoS Pathog</source>
<year>2010</year>;<volume>6</volume>:<fpage>e1000843</fpage>.<pub-id pub-id-type="pmid">20419159</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0009">
<string-name>
<surname>Radoshitzky</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chi</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Clester</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Retterer</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Spurgers</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Sandwick</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ruthel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kota</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Boltz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Warren</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kranzusch</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Whelan</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Bavari</surname>
<given-names>S</given-names>
</string-name>. <article-title>Infectious Lassa virus, but not filoviruses, is restricted by BSTâ2/tetherin</article-title>. <source>J Virol</source>
<year>2010</year>;<volume>84</volume>:<fpage>10569</fpage>â<lpage>10580</lpage>.<pub-id pub-id-type="pmid">20686043</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0010">
<string-name>
<surname>Sakuma</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Noda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Urata</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kawaoka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yasuda</surname>
<given-names>J</given-names>
</string-name>. <article-title>Inhibition of Lassa and Marburg virus production by tetherin</article-title>. <source>J Virol</source>
<year>2009</year>;<volume>83</volume>:<fpage>2382</fpage>â<lpage>2385</lpage>.<pub-id pub-id-type="pmid">19091864</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0011">
<string-name>
<surname>Weidner</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>XB</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Block</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>JT</given-names>
</string-name>. <article-title>Interferonâinduced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms</article-title>. <source>J Virol</source>
<year>2010</year>;<volume>84</volume>:<fpage>12646</fpage>â<lpage>12657</lpage>.<pub-id pub-id-type="pmid">20943977</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0012">
<string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>The antiviral activities of tetherin</article-title>. <source>Curr Top Microbiol Immunol</source>
<year>2013</year>;<volume>371</volume>:<fpage>67</fpage>â<lpage>104</lpage>.<pub-id pub-id-type="pmid">23686232</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0013">
<string-name>
<surname>Le Tortorec</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Willey</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Antiviral inhibition of enveloped virus release by tetherin/BSTâ2: action and counteraction</article-title>. <source>Viruses</source>
<year>2011</year>;<volume>3</volume>:<fpage>520</fpage>â<lpage>540</lpage>.<pub-id pub-id-type="pmid">21994744</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0014">
<string-name>
<surname>Kupzig</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Korolchuk</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rollason</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sugden</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wilde</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Banting</surname>
<given-names>G</given-names>
</string-name>. <article-title>Bstâ2/HM1.24 is a raftâassociated apical membrane protein with an unusual topology</article-title>. <source>Traffic</source>
<year>2003</year>;<volume>4</volume>:<fpage>694</fpage>â<lpage>709</lpage>.<pub-id pub-id-type="pmid">12956872</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0015">
<string-name>
<surname>Hinz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Miguet</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Natrajan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Usami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamanaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Renesto</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hartlieb</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Simorre</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Gottlinger</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Weissenhorn</surname>
<given-names>W</given-names>
</string-name>. <article-title>Structural basis of HIVâ1 tethering to membranes by the BSTâ2/tetherin ectodomain</article-title>. <source>Cell Host Microbe</source>
<year>2010</year>;<volume>7</volume>:<fpage>314</fpage>â<lpage>323</lpage>.<pub-id pub-id-type="pmid">20399176</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0016">
<string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>McNatt</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Zang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>HW</given-names>
</string-name>, <string-name>
<surname>Bieniasz</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Structural insight into the mechanisms of enveloped virus tethering by tetherin</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>;<volume>107</volume>:<fpage>18428</fpage>â<lpage>18432</lpage>.<pub-id pub-id-type="pmid">20940320</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0017">
<string-name>
<surname>Schubert</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Zhai</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Sandrin</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Eckert</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>GarciaâMaya</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Saul</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sundquist</surname>
<given-names>WI</given-names>
</string-name>, <string-name>
<surname>Steiner</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>CP</given-names>
</string-name>. <article-title>Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>;<volume>107</volume>:<fpage>17951</fpage>â<lpage>17956</lpage>.<pub-id pub-id-type="pmid">20880831</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0018">
<string-name>
<surname>PerezâCaballero</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ebrahimi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McNatt</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Gregory</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Bieniasz</surname>
<given-names>PD</given-names>
</string-name>. <article-title>Tetherin inhibits HIVâ1 release by directly tethering virions to cells</article-title>. <source>Cell</source>
<year>2009</year>;<volume>139</volume>:<fpage>499</fpage>â<lpage>511</lpage>.<pub-id pub-id-type="pmid">19879838</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0019">
        <label>19</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0019">
<string-name>
<surname>Iwabu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fujita</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kinomoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kaneko</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ishizaka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tokunaga</surname>
<given-names>K</given-names>
</string-name>. <article-title>HIVâ1 accessory protein Vpu internalizes cellâsurface BSTâ2/tetherin through transmembrane interactions leading to lysosomes</article-title>. <source>J Biol Chem</source>
<year>2009</year>;<volume>284</volume>:<fpage>35060</fpage>â<lpage>35072</lpage>.<pub-id pub-id-type="pmid">19837671</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0020">
        <label>20</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0020">
<string-name>
<surname>Alvarez</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Hamlin</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Monroe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moldt</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hotta</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Rodriguez Caprio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Fierer</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Simon</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>BK</given-names>
</string-name>. <article-title>HIVâ1 Vpu antagonism of tetherin inhibits antibodyâdependent cellular cytotoxic responses by natural killer cells</article-title>. <source>J Virol</source>
<year>2014</year>;<volume>88</volume>:<fpage>6031</fpage>â<lpage>6046</lpage>.<pub-id pub-id-type="pmid">24623433</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0021">
        <label>21</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0021">
<string-name>
<surname>Arias</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Heyer</surname>
<given-names>LN</given-names>
</string-name>, <string-name>
<surname>von Bredow</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Weisgrau</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Moldt</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Burton</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Rakasz</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>DT</given-names>
</string-name>. <article-title>Tetherin antagonism by Vpu protects HIVâinfected cells from antibodyâdependent cellâmediated cytotoxicity</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2014</year>;<volume>111</volume>:<fpage>6425</fpage>â<lpage>6430</lpage>.<pub-id pub-id-type="pmid">24733916</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0022">
        <label>22</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0022">
<string-name>
<surname>Pham</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Lukhele</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hajjar</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Routy</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>EA</given-names>
</string-name>. <article-title>HIV Nef and Vpu protect HIVâinfected CD4+ T cells from antibodyâmediated cell lysis through downâmodulation of CD4 and BST2</article-title>. <source>Retrovirology</source>
<year>2014</year>;<volume>11</volume>:<fpage>15</fpage>.<pub-id pub-id-type="pmid">24498878</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0023">
        <label>23</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0023">
<string-name>
<surname>Veillette</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Coutu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Richard</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Batraville</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Dagher</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Bernard</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tremblay</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kaufmann</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Roger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Finzi</surname>
<given-names>A</given-names>
</string-name>. <article-title>The HIVâ1 gp120 CD4âbound conformation is preferentially targeted by antibodyâdependent cellular cytotoxicityâmediating antibodies in sera from HIVâ1âinfected individuals</article-title>. <source>J Virol</source>
<year>2015</year>;<volume>89</volume>:<fpage>545</fpage>â<lpage>551</lpage>.<pub-id pub-id-type="pmid">25339767</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0024">
        <label>24</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0024">
<string-name>
<surname>Miyakawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ryo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ohba</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamaoka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fukuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>N</given-names>
</string-name>. <article-title>BCA2/Rabring7 promotes tetherinâdependent HIVâ1 restriction</article-title>. <source>PLoS Pathog</source>
<year>2009</year>;<volume>5</volume>:<fpage>e1000700</fpage>.<pub-id pub-id-type="pmid">20019814</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0025">
        <label>25</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0025">
<string-name>
<surname>Galao</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Le Tortorec</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pickering</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kueck</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Innate sensing of HIVâ1 assembly by Tetherin induces NFkappaBâdependent proinflammatory responses</article-title>. <source>Cell Host Microbe</source>
<year>2012</year>;<volume>12</volume>:<fpage>633</fpage>â<lpage>644</lpage>.<pub-id pub-id-type="pmid">23159053</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0026">
        <label>26</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0026">
<string-name>
<surname>Galao</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Pickering</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Curnock</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Retroviral retention activates a Sykâdependent HemITAM in human tetherin</article-title>. <source>Cell Host Microbe</source>
<year>2014</year>;<volume>16</volume>:<fpage>291</fpage>â<lpage>303</lpage>.<pub-id pub-id-type="pmid">25211072</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0027">
        <label>27</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0027">
<string-name>
<surname>Tokarev</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Suarez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kwan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Fitzpatrick</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>J</given-names>
</string-name>. <article-title>Stimulation of NFâkappaB activity by the HIV restriction factor BST2</article-title>. <source>J Virol</source>
<year>2013</year>;<volume>87</volume>:<fpage>2046</fpage>â<lpage>2057</lpage>.<pub-id pub-id-type="pmid">23221546</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0028">
        <label>28</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0028">
<string-name>
<surname>Rollason</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Korolchuk</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Hamilton</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Banting</surname>
<given-names>G</given-names>
</string-name>. <article-title>Clathrinâmediated endocytosis of a lipidâraftâassociated protein is mediated through a dual tyrosine motif</article-title>. <source>J Cell Sci</source>
<year>2007</year>;<volume>120</volume>:<fpage>3850</fpage>â<lpage>3858</lpage>.<pub-id pub-id-type="pmid">17940069</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0029">
        <label>29</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0029">
<string-name>
<surname>Gupta</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Hue</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Schaller</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Verschoor</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pillay</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Towers</surname>
<given-names>GJ</given-names>
</string-name>. <article-title>Mutation of a single residue renders human tetherin resistant to HIVâ1 Vpuâmediated depletion</article-title>. <source>PLoS Pathog</source>
<year>2009</year>;<volume>5</volume>:<fpage>e1000443</fpage>.<pub-id pub-id-type="pmid">19461879</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0030">
        <label>30</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0030">
<string-name>
<surname>Mitchell</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Katsura</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Skasko</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Fitzpatrick</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ruiz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stephens</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>MargottinâGoguet</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Benarous</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Vpu antagonizes BSTâ2âmediated restriction of HIVâ1 release via betaâTrCP and endoâlysosomal trafficking</article-title>. <source>PLoS Pathog</source>
<year>2009</year>;<volume>5</volume>:<fpage>e1000450</fpage>.<pub-id pub-id-type="pmid">19478868</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0031">
        <label>31</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0031">
<string-name>
<surname>Douglas</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Viswanathan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>McCarroll</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Gustin</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Fruh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Moses</surname>
<given-names>AV</given-names>
</string-name>. <article-title>Vpu directs the degradation of the human immunodeficiency virus restriction factor BSTâ2/Tetherin via a {beta}TrCPâdependent mechanism</article-title>. <source>J Virol</source>
<year>2009</year>;<volume>83</volume>:<fpage>7931</fpage>â<lpage>7947</lpage>.<pub-id pub-id-type="pmid">19515779</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0032">
        <label>32</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0032">
<string-name>
<surname>Tokarev</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Munguia</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Serineâthreonine ubiquitination mediates downregulation of BSTâ2/tetherin and relief of restricted virion release by HIVâ1 Vpu</article-title>. <source>J Virol</source>
<year>2011</year>;<volume>85</volume>:<fpage>51</fpage>â<lpage>63</lpage>.<pub-id pub-id-type="pmid">20980512</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0033">
        <label>33</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0033">
<string-name>
<surname>Magadan</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>PerezâVictoria</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Sougrat</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Strebel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bonifacino</surname>
<given-names>JS</given-names>
</string-name>. <article-title>Multilayered mechanism of CD4 downregulation by HIVâ1 Vpu involving distinct ER retention and ERAD targeting steps</article-title>. <source>PLoS Pathog</source>
<year>2010</year>;<volume>6</volume>:<fpage>e1000869</fpage>.<pub-id pub-id-type="pmid">20442859</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0034">
        <label>34</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0034">
<string-name>
<surname>Matheson</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Sumner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wals</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rapiteanu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Weekes</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Vigan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Weinelt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schindler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Antrobus</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Costa</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Frezza</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Clish</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Lehner</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef</article-title>. <source>Cell Host Microbe</source>
<year>2015</year>;<volume>18</volume>:<fpage>409</fpage>â<lpage>423</lpage>.<pub-id pub-id-type="pmid">26439863</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0035">
        <label>35</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0035">
<string-name>
<surname>Magadan</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Bonifacino</surname>
<given-names>JS</given-names>
</string-name>. <article-title>Transmembrane domain determinants of CD4 Downregulation by HIVâ1 Vpu</article-title>. <source>J Virol</source>
<year>2012</year>;<volume>86</volume>:<fpage>757</fpage>â<lpage>772</lpage>.<pub-id pub-id-type="pmid">22090097</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0036">
        <label>36</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0036">
<string-name>
<surname>Schubert</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Strebel</surname>
<given-names>K</given-names>
</string-name>. <article-title>Differential activities of the human immunodeficiency virus type 1âencoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments</article-title>. <source>J Virol</source>
<year>1994</year>;<volume>68</volume>:<fpage>2260</fpage>â<lpage>2271</lpage>.<pub-id pub-id-type="pmid">8139011</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0037">
        <label>37</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0037">
<string-name>
<surname>Mangeat</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>GersâHuber</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lehmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zufferey</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Luban</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Piguet</surname>
<given-names>V</given-names>
</string-name>. <article-title>HIVâ1 Vpu neutralizes the antiviral factor Tetherin/BSTâ2 by binding it and directing its betaâTrCP2âdependent degradation</article-title>. <source>PLoS Pathog</source>
<year>2009</year>;<volume>5</volume>:<fpage>e1000574</fpage>.<pub-id pub-id-type="pmid">19730691</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0038">
        <label>38</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0038">
<string-name>
<surname>Vigan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein</article-title>. <source>J Virol</source>
<year>2010</year>;<volume>84</volume>:<fpage>12958</fpage>â<lpage>12970</lpage>.<pub-id pub-id-type="pmid">20926557</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0039">
        <label>39</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0039">
<string-name>
<surname>Dube</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Paquay</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Roy</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Bego</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Mercier</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>EA</given-names>
</string-name>. <article-title>HIVâ1 Vpu antagonizes BSTâ2 by interfering mainly with the trafficking of newly synthesized BSTâ2 to the cell surface</article-title>. <source>Traffic</source>
<year>2011</year>;<volume>12</volume>:<fpage>1714</fpage>â<lpage>1729</lpage>.<pub-id pub-id-type="pmid">21902775</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0040">
        <label>40</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0040">
<string-name>
<surname>Lau</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kwan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>J</given-names>
</string-name>. <article-title>Role of the endocytic pathway in the counteraction of BSTâ2 by human lentiviral pathogens</article-title>. <source>J Virol</source>
<year>2011</year>;<volume>85</volume>:<fpage>9834</fpage>â<lpage>9846</lpage>.<pub-id pub-id-type="pmid">21813615</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0041">
        <label>41</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0041">
<string-name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fritz</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Bitzegeio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fackler</surname>
<given-names>OT</given-names>
</string-name>, <string-name>
<surname>Keppler</surname>
<given-names>OT</given-names>
</string-name>. <article-title>HIVâ1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction</article-title>. <source>MBio</source>
<year>2011</year>;<volume>2</volume>:<fpage>e00036â11</fpage>.<pub-id pub-id-type="pmid">21610122</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0042">
        <label>42</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0042">
<string-name>
<surname>Dube</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Roy</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>GuiotâGuillain</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Binette</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mercier</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chiasson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>EA</given-names>
</string-name>. <article-title>Antagonism of tetherin restriction of HIVâ1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment</article-title>. <source>PLoS Pathog</source>
<year>2010</year>;<volume>6</volume>:<fpage>e1000856</fpage>.<pub-id pub-id-type="pmid">20386718</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0043">
        <label>43</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0043">
<string-name>
<surname>Dube</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Roy</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>GuiotâGuillain</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mercier</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Binette</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>EA</given-names>
</string-name>. <article-title>Suppression of Tetherinârestricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the transâGolgi network</article-title>. <source>J Virol</source>
<year>2009</year>;<volume>83</volume>:<fpage>4574</fpage>â<lpage>4590</lpage>.<pub-id pub-id-type="pmid">19244337</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0044">
        <label>44</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0044">
<string-name>
<surname>Caillet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Janvier</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>PelchenâMatthews</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>DelcroixâGenete</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Camus</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>BerliozâTorrent</surname>
<given-names>C</given-names>
</string-name>. <article-title>Rab7A is required for efficient production of infectious HIVâ1</article-title>. <source>PLoS Pathog</source>
<year>2011</year>;<volume>7</volume>:<fpage>e1002347</fpage>.<pub-id pub-id-type="pmid">22072966</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0045">
        <label>45</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0045">
<string-name>
<surname>Janvier</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>PelchenâMatthews</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Renaud</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Caillet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>BerliozâTorrent</surname>
<given-names>C</given-names>
</string-name>. <article-title>The ESCRTâ0 component HRS is required for HIVâ1 Vpuâmediated BSTâ2/tetherin downâregulation</article-title>. <source>PLoS Pathog</source>
<year>2011</year>;<volume>7</volume>:<fpage>e1001265</fpage>.<pub-id pub-id-type="pmid">21304933</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0046">
        <label>46</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0046">
<string-name>
<surname>Agromayor</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Soler</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Caballe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kueck</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Freund</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Allen</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Bycroft</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Perisic</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Scheel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hofmann</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>MartinâSerrano</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>RL</given-names>
</string-name>. <article-title>The UBAP1 subunit of ESCRTâI interacts with ubiquitin via a SOUBA domain</article-title>. <source>Structure</source>
<year>2012</year>;<volume>20</volume>:<fpage>414</fpage>â<lpage>428</lpage>.<pub-id pub-id-type="pmid">22405001</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0047">
        <label>47</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0047">
<string-name>
<surname>Roy</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Pacini</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>BerliozâTorrent</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Janvier</surname>
<given-names>K</given-names>
</string-name>. <article-title>Mechanisms underlying HIVâ1 Vpuâmediated viral egress</article-title>. <source>Front Microbiol</source>
<year>2014</year>;<volume>5</volume>:<fpage>177</fpage>.<pub-id pub-id-type="pmid">24822052</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0048">
        <label>48</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0048">
<string-name>
<surname>Kueck</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>A cytoplasmic tail determinant in HIVâ1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferonâinduced restriction</article-title>. <source>PLoS Pathog</source>
<year>2012</year>;<volume>8</volume>:<fpage>e1002609</fpage>.<pub-id pub-id-type="pmid">22479182</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0049">
        <label>49</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0049">
<string-name>
<surname>Tervo</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Homann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ambiel</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Fritz</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Fackler</surname>
<given-names>OT</given-names>
</string-name>, <string-name>
<surname>Keppler</surname>
<given-names>OT</given-names>
</string-name>. <article-title>betaâTrCP is dispensable for Vpu's ability to overcome the CD317/Tetherinâimposed restriction to HIVâ1 release</article-title>. <source>Retrovirology</source>
<year>2011</year>;<volume>8</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">21310048</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0050">
        <label>50</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0050">
<string-name>
<surname>Kueck</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Foster</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Weinelt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sumner</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Pickering</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Neil</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Serine phosphorylation of HIVâ1 Vpu and its binding to tetherin regulates interaction with clathrin adaptors</article-title>. <source>PLoS Pathog</source>
<year>2015</year>;<volume>11</volume>:<fpage>e1005141</fpage>.<pub-id pub-id-type="pmid">26317613</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0051">
        <label>51</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0051">
<string-name>
<surname>Jia</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tokarev</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lewinski</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rizk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Suarez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guatelli</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Structural basis of HIVâ1 Vpuâmediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1</article-title>. <source>Elife</source>
<year>2014</year>;<volume>3</volume>:<fpage>e02362</fpage>.<pub-id pub-id-type="pmid">24843023</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0052">
        <label>52</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0052">
<string-name>
<surname>Carette</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Raaben</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Herbert</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Obernosterer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mulherkar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kuehne</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Kranzusch</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Griffin</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ruthel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dal Cin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dye</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Whelan</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Chandran</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brummelkamp</surname>
<given-names>TR</given-names>
</string-name>. <article-title>Ebola virus entry requires the cholesterol transporter NiemannâPick C1</article-title>. <source>Nature</source>
<year>2011</year>;<volume>477</volume>:<fpage>340</fpage>â<lpage>343</lpage>.<pub-id pub-id-type="pmid">21866103</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0053">
        <label>53</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0053">
<string-name>
<surname>Tchasovnikarova</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Timms</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Matheson</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Wals</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Antrobus</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gottgens</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Dougan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Lehner</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>GENE SILENCING. Epigenetic silencing by the HUSH complex mediates positionâeffect variegation in human cells</article-title>. <source>Science</source>
<year>2015</year>;<volume>348</volume>:<fpage>1481</fpage>â<lpage>1485</lpage>.<pub-id pub-id-type="pmid">26022416</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0054">
        <label>54</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0054">
<string-name>
<surname>Timms</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Duncan</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Tchasovnikarova</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Antrobus</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Dougan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Weekes</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Lehner</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases</article-title>. <source>PLoS Pathog</source>
<year>2013</year>;<volume>9</volume>:<fpage>e1003772</fpage>.<pub-id pub-id-type="pmid">24278019</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0055">
        <label>55</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0055">
<string-name>
<surname>van den Boomen</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Timms</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Grice</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Stagg</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Skodt</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dougan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nathan</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Lehner</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>TMEM129 is a Derlinâ1 associated ERAD E3 ligase essential for virusâinduced degradation of MHCâI</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2014</year>;<volume>111</volume>:<fpage>11425</fpage>â<lpage>11430</lpage>.<pub-id pub-id-type="pmid">25030448</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0056">
        <label>56</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0056">
<string-name>
<surname>Caplan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hartnell</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Aguilar</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Naslavsky</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bonifacino</surname>
<given-names>JS</given-names>
</string-name>. <article-title>Human Vam6p promotes lysosome clustering and fusion in vivo</article-title>. <source>J Cell Biol</source>
<year>2001</year>;<volume>154</volume>:<fpage>109</fpage>â<lpage>122</lpage>.<pub-id pub-id-type="pmid">11448994</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0057">
        <label>57</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0057">
<string-name>
<surname>Kim</surname>
<given-names>BY</given-names>
</string-name>, <string-name>
<surname>Kramer</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kominami</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kohsaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Akazawa</surname>
<given-names>C</given-names>
</string-name>. <article-title>Molecular characterization of mammalian homologues of class C Vps proteins that interact with syntaxinâ7</article-title>. <source>J Biol Chem</source>
<year>2001</year>;<volume>276</volume>:<fpage>29393</fpage>â<lpage>29402</lpage>.<pub-id pub-id-type="pmid">11382755</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0058">
        <label>58</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0058">
<string-name>
<surname>Poupon</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gray</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Piper</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Luzio</surname>
<given-names>JP</given-names>
</string-name>. <article-title>The role of mVps18p in clustering, fusion, and intracellular localization of late endocytic organelles</article-title>. <source>Mol Biol Cell</source>
<year>2003</year>;<volume>14</volume>:<fpage>4015</fpage>â<lpage>4027</lpage>.<pub-id pub-id-type="pmid">14517315</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0059">
        <label>59</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0059">
<string-name>
<surname>Rink</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ghigo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kalaidzidis</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zerial</surname>
<given-names>M</given-names>
</string-name>. <article-title>Rab conversion as a mechanism of progression from early to late endosomes</article-title>. <source>Cell</source>
<year>2005</year>;<volume>122</volume>:<fpage>735</fpage>â<lpage>749</lpage>.<pub-id pub-id-type="pmid">16143105</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0060">
        <label>60</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0060">
<string-name>
<surname>Pols</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>ten Brink</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gosavi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Oorschot</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Klumperman</surname>
<given-names>J</given-names>
</string-name>. <article-title>The HOPS proteins hVps41 and hVps39 are required for homotypic and heterotypic late endosome fusion</article-title>. <source>Traffic</source>
<year>2013</year>;<volume>14</volume>:<fpage>219</fpage>â<lpage>232</lpage>.<pub-id pub-id-type="pmid">23167963</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0061">
        <label>61</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0061">
<string-name>
<surname>Wartosch</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gunesdogan</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Luzio</surname>
<given-names>JP</given-names>
</string-name>. <article-title>Recruitment of VPS33A to HOPS by VPS16 is required for lysosome fusion with endosomes and autophagosomes</article-title>. <source>Traffic</source>
<year>2015</year>;<volume>16</volume>:<fpage>727</fpage>â<lpage>742</lpage>.<pub-id pub-id-type="pmid">25783203</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0062">
        <label>62</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0062">
<string-name>
<surname>Liang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Inn</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Gack</surname>
<given-names>MU</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Vergne</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Akazawa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jung</surname>
<given-names>JU</given-names>
</string-name>. <article-title>Beclin1âbinding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking</article-title>. <source>Nat Cell Biol</source>
<year>2008</year>;<volume>10</volume>:<fpage>776</fpage>â<lpage>787</lpage>.<pub-id pub-id-type="pmid">18552835</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0063">
        <label>63</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0063">
<string-name>
<surname>Manning</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Cantley</surname>
<given-names>LC</given-names>
</string-name>. <article-title>AKT/PKB signaling: navigating downstream</article-title>. <source>Cell</source>
<year>2007</year>;<volume>129</volume>:<fpage>1261</fpage>â<lpage>1274</lpage>.<pub-id pub-id-type="pmid">17604717</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0064">
        <label>64</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0064">
<string-name>
<surname>Inoki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>KL</given-names>
</string-name>. <article-title>Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling</article-title>. <source>Genes Dev</source>
<year>2003</year>;<volume>17</volume>:<fpage>1829</fpage>â<lpage>1834</lpage>.<pub-id pub-id-type="pmid">12869586</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0065">
        <label>65</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0065">
<string-name>
<surname>Xiao</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Shoarinejad</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Golemis</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Yeung</surname>
<given-names>RS</given-names>
</string-name>. <article-title>The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis</article-title>. <source>J Biol Chem</source>
<year>1997</year>;<volume>272</volume>:<fpage>6097</fpage>â<lpage>6100</lpage>.<pub-id pub-id-type="pmid">9045618</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0066">
        <label>66</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0066">
<string-name>
<surname>Barbosa</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>QA</given-names>
</string-name>, <string-name>
<surname>Tchernev</surname>
<given-names>VT</given-names>
</string-name>, <string-name>
<surname>Ashley</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Detter</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Blaydes</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Chotai</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hodgman</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Solari</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Lovett</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kingsmore</surname>
<given-names>SF</given-names>
</string-name>. <article-title>Identification of the homologous beige and ChediakâHigashi syndrome genes</article-title>. <source>Nature</source>
<year>1996</year>;<volume>382</volume>:<fpage>262</fpage>â<lpage>265</lpage>.<pub-id pub-id-type="pmid">8717042</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0067">
        <label>67</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0067">
<string-name>
<surname>Nagle</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Karim</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Woolf</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Holmgren</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bork</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Misumi</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>McGrail</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Dussault</surname>
<given-names>BJ</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Perou</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Boissy</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Duyk</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Spritz</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>KJ</given-names>
</string-name>. <article-title>Identification and mutation analysis of the complete gene for ChediakâHigashi syndrome</article-title>. <source>Nat Genet</source>
<year>1996</year>;<volume>14</volume>:<fpage>307</fpage>â<lpage>311</lpage>.<pub-id pub-id-type="pmid">8896560</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0068">
        <label>68</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0068">
<string-name>
<surname>Cullinane</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Schaffer</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Huizing</surname>
<given-names>M</given-names>
</string-name>. <article-title>The BEACH is hot: a LYST of emerging roles for BEACHâdomain containing proteins in human disease</article-title>. <source>Traffic</source>
<year>2013</year>;<volume>14</volume>:<fpage>749</fpage>â<lpage>766</lpage>.<pub-id pub-id-type="pmid">23521701</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0069">
        <label>69</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0069">
<string-name>
<surname>Gulsuner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tekinay</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Doerschner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Boyaci</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Bilguvar</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Unal</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ors</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Onat</surname>
<given-names>OE</given-names>
</string-name>, <string-name>
<surname>Atalar</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Basak</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Topaloglu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kansu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Gunel</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred</article-title>. <source>Genome Res</source>
<year>2011</year>;<volume>21</volume>:<fpage>1995</fpage>â<lpage>2003</lpage>.<pub-id pub-id-type="pmid">21885617</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0070">
        <label>70</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0070">
<string-name>
<surname>Traka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Millen</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Elbaz</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kidd</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Gomez</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Popko</surname>
<given-names>B</given-names>
</string-name>. <article-title>WDR81 is necessary for purkinje and photoreceptor cell survival</article-title>. <source>J Neurosci</source>
<year>2013</year>;<volume>33</volume>:<fpage>6834</fpage>â<lpage>6844</lpage>.<pub-id pub-id-type="pmid">23595742</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0071">
        <label>71</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0071">
<string-name>
<surname>Sonnhammer</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>von Heijne</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Krogh</surname>
<given-names>A</given-names>
</string-name>. <article-title>A hidden Markov model for predicting transmembrane helices in protein sequences</article-title>. <source>Proc Int Conf Intell Syst Mol Biol</source>
<year>1998</year>;<volume>6</volume>:<fpage>175</fpage>â<lpage>182</lpage>.<pub-id pub-id-type="pmid">9783223</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0072">
        <label>72</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0072">
<string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jian</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jing</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mitani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>. <article-title>Negative regulation of phosphatidylinositol 3âphosphate levels in earlyâtoâlate endosome conversion</article-title>. <source>J Cell Biol</source>
<year>2016</year>;<volume>212</volume>:<fpage>181</fpage>â<lpage>198</lpage>.<pub-id pub-id-type="pmid">26783301</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0073">
        <label>73</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0073">
<string-name>
<surname>Carette</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Guimaraes</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Varadarajan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Wuethrich</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Godarova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kotecki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cochran</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Spooner</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ploegh</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Brummelkamp</surname>
<given-names>TR</given-names>
</string-name>. <article-title>Haploid genetic screens in human cells identify host factors used by pathogens</article-title>. <source>Science</source>
<year>2009</year>;<volume>326</volume>:<fpage>1231</fpage>â<lpage>1235</lpage>.<pub-id pub-id-type="pmid">19965467</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0074">
        <label>74</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0074">
<string-name>
<surname>Carette</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Guimaraes</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Wuethrich</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Blomen</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Varadarajan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Muellner</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Nijman</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Ploegh</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Brummelkamp</surname>
<given-names>TR</given-names>
</string-name>. <article-title>Global gene disruption in human cells to assign genes to phenotypes by deep sequencing</article-title>. <source>Nat Biotechnol</source>
<year>2011</year>;<volume>29</volume>:<fpage>542</fpage>â<lpage>546</lpage>.<pub-id pub-id-type="pmid">21623355</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0075">
        <label>75</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0075">
<string-name>
<surname>Duncan</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Timms</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Zavodszky</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cano</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dougan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Randow</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lehner</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Fluorescenceâbased phenotypic selection allows forward genetic screens in haploid human cells</article-title>. <source>PLoS One</source>
<year>2012</year>;<volume>7</volume>:<fpage>e39651</fpage>.<pub-id pub-id-type="pmid">22745803</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0076">
        <label>76</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0076">
<string-name>
<surname>Jiang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Nishimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sakamaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Itakura</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hatta</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name>. <article-title>The HOPS complex mediates autophagosomeâlysosome fusion through interaction with syntaxin 17</article-title>. <source>Mol Biol Cell</source>
<year>2014</year>;<volume>25</volume>:<fpage>1327</fpage>â<lpage>1337</lpage>.<pub-id pub-id-type="pmid">24554770</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0077">
        <label>77</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0077">
<string-name>
<surname>Khatter</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Raina</surname>
<given-names>VB</given-names>
</string-name>, <string-name>
<surname>Dwivedi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sindhwani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bahl</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>M</given-names>
</string-name>. <article-title>The small GTPase Arl8b regulates assembly of the mammalian HOPS complex on lysosomes</article-title>. <source>J Cell Sci</source>
<year>2015</year>;<volume>128</volume>:<fpage>1746</fpage>â<lpage>1761</lpage>.<pub-id pub-id-type="pmid">25908847</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0078">
        <label>78</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0078">
<string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Akazawa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>T</given-names>
</string-name>. <article-title>RILP interacts with HOPS complex via VPS41 subunit to regulate endocytic trafficking</article-title>. <source>Sci Rep</source>
<year>2014</year>;<volume>4</volume>:<fpage>7282</fpage>.<pub-id pub-id-type="pmid">25445562</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0079">
        <label>79</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0079">
<string-name>
<surname>Smith</surname>
<given-names>TF</given-names>
</string-name>. <article-title>Diversity of WDârepeat proteins</article-title>. <source>Subcell Biochem</source>
<year>2008</year>;<volume>48</volume>:<fpage>20</fpage>â<lpage>30</lpage>.<pub-id pub-id-type="pmid">18925368</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0080">
        <label>80</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0080">
<string-name>
<surname>Smith</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Gaitatzes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Saxena</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Neer</surname>
<given-names>EJ</given-names>
</string-name>. <article-title>The WD repeat: a common architecture for diverse functions</article-title>. <source>Trends Biochem Sci</source>
<year>1999</year>;<volume>24</volume>:<fpage>181</fpage>â<lpage>185</lpage>.<pub-id pub-id-type="pmid">10322433</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0081">
        <label>81</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0081">
<string-name>
<surname>Ran</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Agarwala</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>F</given-names>
</string-name>. <article-title>Genome engineering using the CRISPRâCas9 system</article-title>. <source>Nat Protoc</source>
<year>2013</year>;<volume>8</volume>:<fpage>2281</fpage>â<lpage>2308</lpage>.<pub-id pub-id-type="pmid">24157548</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0082">
        <label>82</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0082">
<string-name>
<surname>KoikeâYusa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>EP</given-names>
</string-name>, <string-name>
<surname>VelascoâHerrera Mdel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yusa</surname>
<given-names>K</given-names>
</string-name>. <article-title>Genomeâwide recessive genetic screening in mammalian cells with a lentiviral CRISPRâguide RNA library</article-title>. <source>Nat Biotechnol</source>
<year>2014</year>;<volume>32</volume>:<fpage>267</fpage>â<lpage>273</lpage>.<pub-id pub-id-type="pmid">24535568</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0083">
        <label>83</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0083">
<string-name>
<surname>Miyagi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Andrew</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Kao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Strebel</surname>
<given-names>K</given-names>
</string-name>. <article-title>Vpu enhances HIVâ1 virus release in the absence of Bstâ2 cell surface downâmodulation and intracellular depletion</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2009</year>;<volume>106</volume>:<fpage>2868</fpage>â<lpage>2873</lpage>.<pub-id pub-id-type="pmid">19196977</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0084">
        <label>84</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0084">
<string-name>
<surname>Burke</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Schooler</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wiley</surname>
<given-names>HS</given-names>
</string-name>. <article-title>Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking</article-title>. <source>Mol Biol Cell</source>
<year>2001</year>;<volume>12</volume>:<fpage>1897</fpage>â<lpage>1910</lpage>.<pub-id pub-id-type="pmid">11408594</pub-id></mixed-citation>
      </ref>
      <ref id="tra12409-bib-0085">
        <label>85</label>
        <mixed-citation publication-type="journal" id="tra12409-cit-0085">
<string-name>
<surname>Villasenor</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nonaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Del ConteâZerial</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kalaidzidis</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zerial</surname>
<given-names>M</given-names>
</string-name>. <article-title>Regulation of EGFR signal transduction by analogueâtoâdigital conversion in endosomes</article-title>. <source>Elife</source>
<year>2015</year>;<volume>4</volume>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>